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The development of multicellular organisms requires a tight coordination of
cell proliferation, cell differentiation and cell death in order to correctly
specify cell fate and number. According to the trophic theory of survival,
this is achieved in part by a competition between cells in a tissue for a
limited number of extracellular survival factors. Cells that do not receive
sufficient quantities of these survival cues engage a default cell death
program and are thereby eliminated. This ‘social control’ of cell survival
ensures the integrity of tissues by matching the correct number of different
cell types to each other.

Apoptosis is one morphologically distinct,

genetically programmed form of cell death by which cells in an organism are
efficiently and rapidly removed.

The proper execution of apoptosis is

therefore critical to normal development and homeostasis in metazoans and
defects in the regulation of apoptosis is known to contribute to the etiology
of several major diseases.

Initial insights into the complex molecular

networks that regulate apoptosis derived largely from elegant genetic

analyses of invertebrate model organisms. These early studies identified
several genes critical for the execution of the apoptosis and established an
evolutionarily conserved core cell death pathway. To further elucidate the
molecular mechanisms underlying the control of apoptosis, we conducted
several mutagenesis screens in Drosophila melanogaster to identify genes
that can modulate cell death phenotypes. One particularly interesting mutant
isolated in these screens was recovered as a strong, specific and dominant
suppressor of cell death induced by the RHG protein hid. We demonstrate
that this mutant is a gain-of-function allele of ras85D (ras1), the Drosophila
homolog of mammalian oncogenes H-ras, K-ras and N-ras. We further
establish that this viable allele, rasR68Q, contains a mutation in the Switch II
region of Ras and that it produces a GTPase protein with diminished
enzymatic activity. RasR68Q is the first endogenous gain-of-function ras1
allele to be identified in Drosophila and represents one of very few
hypermorphic Ras mutations compatible with organismal viability to be
isolated.
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CHAPTER 1.
Introduction

1

Programmed Cell Death
Animal development encompasses not only cell proliferation, but also
highly regulated cell death. Biologists have recognized the occurrence of
cell death in multicellular organisms as a normal physiological event for
more than 150 years (Glucksmann, 1951). The term programmed cell death
(PCD) was first introduced in 1964 following the characterization of
intersegmental muscle degeneration during pupation in the silkmoth. Noting
the “carefully timed” and ecdysone dependent nature of cellular dissolution
in this organism, the authors posited the concept that cell death during
development is not of an accidental or random nature, but rather follows a
sequence of precisely controlled steps that ultimately lead to spatially and
temporally defined cell deaths (Lockshin and Williams, 1964).
The manner in which a cell dies can vary tremendously from
paradigm to paradigm, rendering it difficult to study the general phenomena
of cell death in a systematic manner. The framework for scientific inquiry
into the mechanisms regulating PCD was significantly advanced in 1972
when the Scottish pathologists Andrew H. Wyllie, John F. Kerr and A.R.
Currie coined the term “apoptosis” to describe a common and stereotypic
subset of cell deaths (Kerr et al., 1972).

Apoptosis describes a

morphologically distinct form of cell death that is accompanied by rounding-
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up of the cell, retraction of pseudopodia, reduction of cellular volume
(pyknosis), condensation of the chromatin, fragmentation of the nucleus
(karyorhexis), little or no ultrastructural modification of cytoplasmic
organelles, plasma membrane blebbing, and maintenance of an intact plasma
membrane until late stages of the process (Bellairs, 1961; Kroemer et al.,
2005). Unlike necrosis, which typically occurs as a result of toxic cellular
insults, apoptosis was observed to occur in a regulated manner as a normal
part of animal development. Kerr et al further noted that, in contrast to
necrosis, cells eliminated by apoptosis were removed rapidly and efficiently
without eliciting an inflammatory response.

In addition to the above

morphological criteria, apoptosis has subsequently become associated with a
number of biochemical changes including loss of membrane phospholipid
asymmetry, DNA fragmentation, activation of caspases and activation of
nucleases (Hengartner, 2000).
It is now appreciated that PCD is an active, gene-directed process
essential for the proper growth, morphogenesis and homeostasis of
metazoans. Apoptosis is used extensively in animal development for the
removal of unnecessary cells and structures, the sculpting of tissues, the
adjustment of cell numbers and as a defensive strategy to remove infected,
mutated, or damaged cells (Jacobson et al., 1997; Vaux and Korsmeyer,
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1999). Classic examples of the use of apoptosis in developmental biology
include; deletion of the tadpole tail during metamorphosis into an adult frog
(Tata, 1994), formation of free and independent digits by removal of
interdigital mesenchymal cells during limb pattern formation (Mori et al.,
1995), culling of greater than 50% of neurons by apoptosis during
maturation of the vertebrate brain (Yuan and Yankner, 2000), and formation
of vertebrate reproductive organs by deletion of the Wolffian duct in females
or of the Müllerian duct in males (Meier et al., 2000a).
Given the integral role of apoptosis in animal development and
homeostasis, it is perhaps not surprising that defects in the regulation of
apoptosis can contribute to the etiology of several major diseases. Excess
apoptosis is a characteristic of many neurological diseases which exhibit the
gradual loss of specific sets of neurons, resulting in disorders of movement
and CNS function (Sastry and Rao, 2000). Diseases for which excess
apoptosis is believed to play a causal role include Parkinson’s disease,
amyotrophic lateral sclerosis, retinitis pigmentosa, several forms of
cerebellar degeneration, spinal muscular atrophy and Alzheimer’s disease
(Thompson, 1995). In contrast, a reduction in apoptosis is associated with
cancer and autoimmunity. In cancer for example, inappropriate activation of
the negative regulator of apoptosis, Bcl-2, is associated with non-Hodgkin’s
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lymphomas (Tsujimoto et al., 1985).

Similarly, inactivation of Bax, a

positive regulator of cell death, is associated with colon, gastrointestinal and
hematological malignancies (Meijerink et al., 1995; Rampino et al., 1997;
Yamamoto et al., 1997).
Extensive research efforts conducted into the subject of programmed
cell death over the last two decades have yielded a detailed understanding of
many of the mechanisms and pathways involved in this vital biological
phenomenon. It is now recognized for example, that programmed cell death
can occur through several diverse mechanisms that lead to a variety of
distinct cell death morphologies (Kroemer et al., 2005). In response to this
greatly improved understanding, a multitude of novel terms have arisen to
describe these varied types of cell death including, apoptosis, necrosis,
autophagy (Levine and Klionsky, 2004), mitotic catastrophe (Castedo et al.,
2004), anoikis (Frisch and Screaton, 2001), excitotoxicity (Orrenius et al.,
2003) and cornification (Candi et al., 2005). Recently, there has been a
surge of interest in type II or autophagic cell death, which is distinguished
from apoptosis by a stereotypical degradation of the Golgi apparatus,
polyribosomes, and endoplasmic reticulum prior to nuclear destruction
(Bursch et al., 2000; Martin and Baehrecke, 2004). Apoptosis however, is
by far the most studied and best understood form of programmed cell death,

5

with publications on the subject surpassing 70000 to date (Yuan and
Horvitz, 2004).
The ‘modern era’ of apoptosis research and an exponential leap of
interest in the field was heralded by the identification of several biochemical
and genetic processes that govern it.

That programmed cell death is

genetically controlled was appreciated by the late 1960’s pursuant to the
demonstration by several labs that the inhibition of protein synthesis could
prevent cell death (Lockshin, 1969; Makman et al., 1971; Tata, 1966). It
was not until 1988 however that the first molecular component of apoptosis,
Bcl-2, was identified as the product of a gene found to be activated by the
t(14;18) chromosomal translocation in follicular lymphoma (Adams and
Cory, 1998; Vaux et al., 1988). Unlike previously described oncogenes such
as c-myc or abl which were known to be promoters of cell proliferation, bcl2 did not stimulate cell division, but rather prevented cells from dying when
growth factor was removed. Hence, in addition to identifying a molecular
component of the apoptotic mechanism, this discovery established that
inhibition of cell death could contribute to the development of cancer in
humans.
The first direct evidence that a genetic program exists purely for
physiological cell death came from groundbreaking screens in the model

6

genetic organism Caenorhabditis elegans (C. elegans), a nematode with an
invariant, lineage-restricted development that renders this organism ideal for
the genetic study of programmed cell death. During ontogeny of the adult
hermaphrodite worm, precisely 131 of the 1,090 somatic cells predictably
die by apoptosis, leaving an adult comprised of exactly 959 cells of known
origin (Sulston and Horvitz, 1977; Sulston et al., 1983). Genetic screens in
C. elegans subsequently identified three genes, egl-1, ced-4 and ced-3 that
are essential for the execution of cell death in this organism.

Loss-of-

function mutations in any one of these genes disables the apoptotic program
and leads to the survival of all somatic cells that normally die by apoptosis
during wild-type C. elegans development (Conradt and Horvitz, 1998; Ellis
and Horvitz, 1986). Conversely, a fourth gene, ced-9, was discovered to be
absolutely required for protection against unscheduled cell deaths in C.
elegans since null mutations in ced-9 result in extensive ectopic apoptosis
during development (Hengartner et al., 1992). The remarkable power of
such genetic analyses in C. elegans has led to the identification of more than
20 genes that function in programmed cell death and has permitted these
genes to be ordered into a coherent genetic pathway. For their pioneering
contributions to developmental genetics and programmed cell death, Sydney
Brenner, Robert Horvitz and John Sulston received the Nobel Prize in
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Physiology or Medicine in 2002 (Brenner, 2003; Horvitz, 2003; Sulston,
2003).
The independent discovery that human Bcl-2 could prevent
programmed cell death in C. elegans indicated that apoptosis in mammalian
cells and programmed cell death in the nematode were highly related
processes.

This insight rapidly progressed to the wider realization that

apoptosis is in fact an ancient, evolutionarily conserved phenomenon that
operates in virtually all multicellular organisms and thereby validated the
use of genetic models to better understand the apoptotic process in human
development and disease (Vaux et al., 1992).

These genetic and other

studies ultimately established that many components of the core apoptotic
pathway originally described in C. elegans by Horvitz et al. are highly
conserved amongst animals as diverse as the fly, the mouse and humans
(Danial and Korsmeyer, 2004).

Discovery of Caspases
A critical advancement in our understanding of the biochemical
mechanisms regulating apoptosis came in 1993 with the cloning of ced-3
and the discovery that it encodes a protein similar to the mammalian
cysteine protease, interleukin-1B-converting enzyme (ICE) (Yuan et al.,
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1993). This finding firmly established a role for the cysteine aspartatespecific proteases (caspases) as cell death effectors and proclaimed the
discovery of a molecular mechanism for apoptosis in C. elegans.

The

discovery that ced-3 encodes a cysteine protease was completely unexpected
and indicated a mechanism of action that had not been anticipated.
Overexpression studies with the newly cloned protein determined that Ced-3
could induce the death of mammalian cells in a cell-autonomous fashion and
suggested that both Ced-3 and mammalian caspases cause cells to die by a
mechanism more direct than that of a hormone or a transcription factor
(Miura et al., 1993).
Since the discovery of their role in apoptosis, expansive efforts have
focused on the identification of caspases and on the analysis of their
regulation and biological functions. Certain caspases, such as ICE (now
known as caspase-1) had already been long examined for their non-apoptotic
functions, such as in the regulation of inflammation (Cerretti et al., 1992).
The regulatory functions of caspases in apoptosis and in a number of other
biological processes have now also been studied in detail.

Caspases

constitute a family of cysteine aspartyl specific proteases that are highly
conserved amongst metazoans and in addition to functioning as central
regulators of apoptosis, caspases participate in the regulation and execution
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of a number of critical cellular processes such as the cell cycle, DNA
replication, DNA repair, inflammation and differentiation (Fischer et al.,
2003; Kuranaga and Miura, 2007; Thornberry and Lazebnik, 1998).
There has been a clear evolutionary tendency to increase the number
of caspases over phylogenetic time, from four in C. elegans to seven in
Drosophila, ten in mice and eleven to twelve distinct caspases in humans
(caspase 12 is a pseudogene in whites and is functional in a subset of
individuals of African descent) (Lamkanfi et al., 2002; Shaham, 1998; Xue
et al., 2006). Caspases that participate in apoptosis can be broadly classified
into the initiator caspase group and the effector caspase group based on
domain architecture and physiologic function (Fig 1.1). Initiator caspases
typically occur in the cytosol as inactive monomers, contain long N-terminal
prodomains that encode related homotypic oligomerization motifs such as
the caspase recruitment domain (CARD) or the death effector domain
(DED) and provide a link between cell signaling and apoptotic execution. In
contrast, effector caspases often exist as dimers in their inactive form,
contain a short prodomain that lacks death domains and are thought to act
downstream of initiator caspases as the ultimate executors of cell death
(Degterev et al., 2003; Turk and Stoka, 2007).
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Fig 1.1. Domain architecture of caspases in flies, mammals and worm.
Initiator caspases contain prodomains such the CARD or DED and are
labeled in blue, whereas executioner caspases lack prodomains and are
labeled in black. Those caspases for which a clearly defined role in cell
death has been demonstrated are labeled in bold. Drosophila contains 7
caspases, of which 4 are known to be involved in cell death, Dredd, Dronc,
Drice and Dcp-1. In mammals, 7 of the 11 identified caspases participate in
apoptosis, including the initiator Caspases-2,-8,-9 and -10 and the
executioner Caspases-3,-6 and -9. A possible role in cell death for other
caspases however can not yet be excluded.
initiator and executioner caspase.

Ced-3 behaves as both an

Approximate sites for proteolytic

processing of zymogens are indicated by black arrows above Ced-3. CARD,
Caspase Recruitment Domain; DED, Death Effector Domain.
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Like most proteases, caspases are generally synthesized as weakly
active proenzymes or zymogens consisting of an inhibitory N-terminal
prodomain, followed by a large and then a small protease subunit.
Overwhelming structural and biochemical evidence predicts that active
caspases are obligate heterotetramers composed of two identical catalytic
units, with each catalytic unit containing one active site. Currently, all threedimensional structures of caspases in their active form reveal that each
catalytic unit is composed of one large and one small subunit derived from
the same precursor molecule (Fuentes-Prior and Salvesen, 2004). Subunits
are generated by the sequential cleavage of precursors at specific aspartate
residues delineated by a four-amino acid recognition motif within zones of
the precursor protein termed the ‘linker regions’.
These structural observations led to the assumption that caspases are
activated and therefore regulated by proteolytic cleavage (Shi, 2002).
Though this has been shown to hold true for the effector class of caspases,
recent studies have revealed that cleavage is neither required nor sufficient
for activation of the initiator caspases (Boatright et al., 2003). Instead,
activation of initiator caspases is effected by an oligomerization process that
brings multiple procaspase molecules into close proximity via formation of
large multiprotein complexes. Evidence for this ‘induced-proximity’ model
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of caspase activation comes from well-studied caspase complexes such as
the apoptosome, the death inducing signaling complex (DISC), the
PIDDosome and the caspase-1-containing inflammasome (Festjens et al.,
2006). Activator proteins drive multimerization of initiator caspases via
homotypic interactions between the death domains found in the long
prodomains of initiator caspases and those found in the activators. In C.
elegans, the CARD containing caspase Ced-3 is activated by its recruitment
into a complex containing the activator Ced-4, while in Drosophila, the
CARD containing initiator caspase Dronc is activated via recruitment to an
oligomeric complex containing the activator Ark/Hac-1, which is
homologous to Ced-4. Activation of mammalian DED containing caspase-8
and CARD containing caspase-9 is similarly mediated by recruitment into
large multimeric complexes, namely, the DISC and the apoptosome,
respectively.

The ‘induced-proximity’ model of caspase activation is

discussed in greater detail in the next section.
Once activated, caspases target and cleave various proteins in order to
execute their apoptotic or nonapoptotic functions.

In addition to

autocleaving within activation complexes, a major target of initiator
caspases are the effector (downstream) caspases, which in turn mediate the
cleavage of a large number of cellular substrates. The execution phase of
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apoptosis is thought to result from the limited caspase-dependent cleavage of
hundreds of cellular proteins the sum of which results in the morphology
characteristic of this form of programmed cell death. Interestingly, the death
signals generated by the caspase proteolysis of target proteins are propagated
in both an upstream and downstream fashion. For example, downstream
effector caspases cleave initiator caspases and other upstream signaling
molecules and in this manner generate positive feedback loops in the caspase
signaling cascade.

This combination of positive feedback with the

irreversible nature of caspase cleavage results in a highly efficient molecular
mechanism for executing cell death that is both rapid and inexorable once
initiated (Turk, 2006).

The efficacy of the apoptotic program can be

visualized by time-lapse videomicroscopy, which has demonstrated that
apoptotic cell death, from initiation to phagocytic removal of cell corpses,
can be extremely rapid, often being completed in 20 min or less. This
rapidity can regularly lead to a substantial underestimation of apoptotic rates
in many experimental paradigms (Evan et al., 1992).
Understanding the many discrete and interacting signaling pathways
mediated by caspases will require identification of the natural substrate
repertoire for each caspase. Although more than 280 caspase substrates
have thus far been identified in humans, it appears that many more apoptotic
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caspase targets have yet to been revealed, a task complicated by the
overlapping substrate specificities of multiple caspase family members
(Fischer et al., 2003).

Recent advances in technology, such as mRNA

display, have allowed for enhanced identification of natural caspase
substrates with improved delineation of caspase substrate repertoires and
should improve our understanding of the molecular pathways underpinning
programmed cell death (Ju et al., 2007).

Intrinsic Activation of Caspases
Although there are four caspase-like proteins in C. elegans, Ced-3 is
the only one that has been shown to be required for apoptosis and in this
regard, Ced-3 uniquely behaves as both an initiator and executor caspase
(Ellis and Horvitz, 1986; Shaham, 1998). Genetic screens and epistasis
experiments in C. elegans have established that the central and most
downstream step in the execution of cell death is the activation of Ced-3 and
that Egl-1, Ced-9 and Ced-4 act as upstream regulators for essentially all
developmental cell deaths (Shaham and Horvitz, 1996). In addition to these
genetic studies, most of the protein complexes that are postulated to be
involved in the activation of Ced-3 have been crystallized, allowing for a
detailed mechanistic analysis of apoptosis activation in C. elegans. These
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structural and biochemical data demonstrate that initiation of the apoptotic
cascade is achieved through a series of direct protein-protein interactions.
According to the ‘induced proximity’ model of caspase activation, active
Ced-3 is generated by recruitment of several proCed-3 molecules into a
tetrameric Ced-4 complex (Yan et al., 2005; Yang et al., 1998). In the
absence of apoptotic stimuli, Ced-4 is sequestered as an inactive dimer on
the outer surface of mitochondria by a direct interaction with mitochondriabound Ced-9 (Spector et al., 1997; Wu et al., 1997). In cells destined to die,
developmental or external cues lead to Egl-1 expression, which binds to and
induces a conformational change in Ced-9, thereby disrupting the Ced-4Ced-9 interaction and discharging Ced-4 from the mitochondrial surface into
the cytosol (Conradt and Horvitz, 1998). Once liberated, Ced-4 dimers
oligomerize into the tetrameric complex to which proCed-3 molecules are
recruited, cleaved and activated (del Peso et al., 1998).
Despite a disparity in many of the details, several components and
functional aspects of this core C. elegans pathway are evolutionarily
conserved in flies and mammals as part of the intrinsic or mitochondrial
pathway of caspase activation.

In mammals, a member of the initiator

caspase family, caspase-9, is a critical mediator of the intrinsic apoptotic
pathway (Hakem et al., 1998; Kuida et al., 1998). Likewise in Drosophila,
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the initiator caspase Dronc is required for virtually all programmed cell
death during embryogenesis (Chew et al., 2004; Daish et al., 2004). Ced-4,
an adaptor protein of the P-loop ATPase family, is homologous to
mammalian apoptotic protease-activating factor-1 (Apaf-1) and Drosophila
Ark/Hac-1.

These adaptor proteins contain a CARD followed by a

nucleotide-binding/oligomerization domain and directly bind the CARD of
initiator caspases to mediate apoptosome formation and caspase activation.
Ced-9 is an anti-apoptotic member of the Bcl-2 family of proteins,
containing four Bcl-2 homology (BH) domains and sharing homology with
several mammalian Bcl-2 family proteins that regulate apoptosis at the level
of the mitochondria (Danial and Korsmeyer, 2004; Hengartner and Horvitz,
1994). Finally, Egl-1 is a pro-apoptotic BH3-only protein that again shares
significant homology with several mammalian apoptotic regulators (Cory et
al., 2003). In Drosophila, the multidomain Bcl-2 family members Debcl
and Buffy have been shown to localize to mitochondrial and ER membranes
respectively and to have pro- and anti-apoptotic effects in certain contexts,
however evidence for their role in the regulation of apoptosis remains
limited (Doumanis et al., 2007; Igaki et al., 2000; Igaki and Miura, 2004;
Quinn et al., 2003). In any event, the study of apoptosis in C. elegans has
clearly been instrumental in the identification of several key components of
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an apoptotic cascade that is now known to be highly conserved throughout
evolution.
It is equally evident however, that distinct mechanisms and modalities
of control over caspase activity have evolved amongst various organisms,
typically with an increasingly complex network of regulators being utilized
over phylogenetic time. The C. elegans genome, for example, encodes only
three Bcl-2 family members (ced-9, ced-13 and egl-1) whereas mammals
possess a panoply of more than 20 (Cory et al., 2003).

One apparent

difference between species in the regulation of caspase dependent cell death
concerns the role of mitochondria and their release of apoptogenic
intermembrane space proteins. In mammals, mitochondria have been well
substantiated as a critical control point for apoptosis induction, regulating
death signals via a mitochondrial outer membrane permeabilization event
that discharges into the cytosol several putative pro-apoptotic factors
including cytochrome c, SMAC/Diablo, Omi/HTRA2, endonuclease G,
apoptosis inducing factor (AIF) and ARTS (Green and Kroemer, 2004;
Larisch et al., 2000; Wang, 2001). The various pro- and anti-apoptotic Bcl-2
family members in turn regulate this critical permeabilization event through
mechanisms that remain controversial.
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Perhaps the best studied role for mitochondria in the regulation of
mammalian apoptosis concerns the release of cytochrome c.

Upon its

discharge from mitochondria into the cytoplasm during a permeabilization
event, cytochrome c binds to the WD40 repeats of Apaf-1, inducing a
conformational change in Apaf-1 that permits its oligomerization with and
subsequent activation of Caspase-9 (Li et al., 1997). This is in marked
contrast to Ced-4 in C. elegans, which lacks a WD40 domain and does not
require cytochrome c for its activity in vitro (Yan et al., 2005). Likewise in
Drosophila, biochemical and structural evidence to support a role for either
mitochondria or cytochrome c in Ark/Hac-1 dependent cell death has not
been forthcoming despite the fact that Ark/Hac-1 does contain C-terminal
WD40 repeats and is able to bind cytochrome c (Yu et al., 2006). However,
recent genetic data from both C. elegans and Drosophila does support at
least some role for mitochondria in caspase dependent cell death in these
organisms. Two mitochondrial proteins, CPS-6 and WAH-1, which are the
C. elegans homologues of mammalian endonuclease G and AIF
respectively, are released from mitochondria during apoptotic stimuli and
synergize to promote DNA degradation (Parrish et al., 2001; Wang et al.,
2002).

In Drosophila, a homolog of the mitochondrial serine protease

Omi/HTRA2 was recently cloned and shown to efficiently promote cell
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death in a manner analogous to its mammalian counterpart (Igaki et al.,
2007).

Additional in vivo evidence from Drosophila indicates that a

particular form of cytochrome c, cyt-c-d, is required for caspase activation
during spermatid differentiation and for the proper regulation of
developmental apoptosis in the pupal eye (Arama et al., 2006; Mendes et al.,
2006). Mitochondrial disruption, which is a conserved aspect of apoptosis
involving the mitochondrial fission mediator Drp1, has been observed in
both C. elegans and Drosophila and has been found to affect programmed
cell death (Goyal et al., 2007; Jagasia et al., 2005). Finally, there is evidence
that the Drosophila cell death inducers rpr, hid and grim (the so called RHG
proteins - see below) require mitochondrial localization via a mitochondrial
targeting sequence referred to as the GH3 domain for full apoptotic activity
(Freel et al., 2008).

Extrinsic Activation of Caspases
A major point of divergence between C. elegans and higher organisms
in the regulation of caspases relates to the evolution in the latter of a second,
alternative pathway for caspase activation. This pathway, referred to as the
extrinsic cell death pathway, is mediated by transmembrane death receptors
of the tumor necrosis factor receptor (TNFR) superfamily. In mammals this
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includes

Fas/CD95/Apo1,

TNF-R1,

TNF-R2,

DR3/WSL-1/TRAMP,

DR4/TRAIL-R1, DR5/TRAIL-R2, and DR6, all of which are characterized
by the presence of a cytoplasmic death domain (DD). Activation of this
pathway is initiated by ligand-induced receptor trimerization when members
of the TNF superfamily of ligands, either soluble or membrane bound, bind
their cognate death receptors. The recruitment and activation of initiator
caspases is subsequently achieved by adapter molecules that bridge activated
death receptors to initiator procaspases via homophilic death domain and
death effector domain (DED) contacts (Ho and Hawkins, 2005; Park et al.,
2007). Fas, upon ligand stimulation by FasL, recruits the adapter protein
FADD to its cytoplasmic tail via a homotypic DD:DD interface. FADD in
turn recruits caspase-8 or caspase-10, via homotypic interactions with the
tandem DED motifs found within the prodomain of these caspases,

to

generate the ternary death-inducing signaling complex (DISC). In the case
of TNFR1 activation by TNF-α, the multifunctional adapter protein TRADD
is first recruited to the activated receptor again via a DD interaction.
TRADD in turn engages receptor-interacting protein (RIP) and the TNF
receptor-associated factors (TRAFs) to form the membrane-bound ‘complex
I’, essential for IKK and NF-κB activation.

Subsequently, TRADD

dissociates from TNFR1 and associates with FADD and caspase-8 to
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generate the cytoplasmic ‘complex II’, a platform for caspase activation.
The regulated assembly of these two different TRADD complexes may
underlie the ability of TNF to induce either cell death or cell survival under
different cellular contexts (Micheau and Tschopp, 2003b).

Ultimately,

recruitment of procaspases into these high molecular mass complexes
induces the proteolytic autoprocessing of zymogens via an inducedproximity mechanism similar to that described for the apoptosome. This
liberates active caspase-8 or caspase-10 into the cytoplasm to cleave and
activate downstream effector caspases such as caspase-3 and caspase-7,
generating a caspase signaling cascade.

Induction of apoptosis via the

extrinsic pathway is used extensively in cells of the immune system to
eliminate immune effector cells that have fulfilled their function and defects
in

components

of

this

pathway

manifest

as

an

autoimmune

lymphoproliferative syndrome (ALPS) (Rieux-Laucat et al., 2003).
Additionally, mutations in caspase-8 have been linked to a variety of human
cancers, suggesting that caspases-8 can act as a tumor suppressor.
The fly genome clearly encodes an ortholog of FADD, designated
dFADD, that like its mammalian counterpart, binds to and activates an
apical caspase, Dredd (Hu and Yang, 2000).

Also encoded by the

Drosophila genome are two TRAF homologs, dTRAF1 and dTRAF2, a
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single TNF ligand, Eiger and a single putative TNFR homolog, Wengen,
which contains an extracellular TNFR homology domain but lacks the
intracellular DD motif characteristic of the death receptor family (Igaki et
al., 2002; Kanda et al., 2002; Liu et al., 1999). Despite the expression of this
TNF-like axis in Drosophila however, current evidence argues that it
probably does not engage the dFADD/Dredd module to launch an apoptotic
caspase cascade.

Instead, the dFADD/Dredd module predominantly

regulates innate immune responses triggered by Gram negative bacteria
(Tanji and Ip, 2005). Nevertheless, Eiger is a potent inducer of apoptosis
and represents the first TNF cytokine superfamily ligand to be isolated in an
invertebrate. Originally identified in a gain-of-function screen for inducers
of apoptosis, Eiger is a type II transmembrane protein with a C-terminal
TNF homology domain, is predominantly expressed in the nervous system,
and can be cleaved and released from the cell surface as a soluble factor.
Genetic analysis of Eiger mutants revealed that the apoptotic effect of Eiger
does not require the activity of dFADD/Dredd, but instead is completely
dependent upon on its ability to activate the Jun-N-terminal kinase (JNK)
pathway. Precisely how Eiger achieves activation of JNK and the role of
Wengen in this pathway remains controversial. Recent evidence suggests
that dTRAF2, the Drosophila homolog of the human tumor suppressor and
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deubiquitinating enzyme CYLD, dCYLD, and the ubiquitination activity of
Diap1, all play a critical role in transduction and modulation of the Eiger
signal (Xue et al., 2007). It seems clear from an phylogenetic perspective
that the extrinsic pathway of apoptosis induction represents a relatively
recent evolutionary event, largely confined to mammals, whereas the
intrinsic pathway is the more ancient, evolutionarily conserved mechanism
of caspase activation.

Discovery of the RHG Proteins
Another pointed example of how evolution has led to the emphasis of
discrete regulatory points of control over the execution of programmed cell
death was imparted by the discovery in Drosophila of a novel class of
apoptotic regulatory proteins referred to as the RHG proteins.

D.

melanogaster has proven an excellent model in which to examine
programmed cell death, with many advantages, including a well documented
developmental plasticity, a rapid life cycle, sophisticated genetic tools, welldeveloped misexpression systems, a largely complete and annotated genome
sequence and a wealth of current and historical research literature.
Furthermore, multiple tissues undergo programmed cell death in a globally
patterned yet dynamically stochastic manner throughout Drosophila
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development, affording the opportunity to analyze the complex regulatory
decisions that control these cell deaths. Cell death has been characterized in
the Drosophila embryonic central nervous system, embryonic head region,
embryonic epidermis, larval salivary glands, larval midgut, larval wing and
eye imaginal discs, pupal retina, adult nervous system and adult female germ
line (Gorski and Marra, 2002). Drosophila was propelled to the forefront of
apoptosis research in 1994 when a deficiency screen conducted using the
vital dye Acridine Orange, a marker of dying cells, identified a chromosomal
region essential for virtually all embryonic cell deaths, as well as ectopic
deaths induced by irradiation and developmental defects (White et al., 1994).
Subsequent analysis of this region, spanning 75C1-2 and deleted in the H99
deficiency, led to the identification of three genes that function in the
activation of cell death: reaper (rpr), head involution defective (hid) and
grim (Chen et al., 1996; Grether et al., 1995; White et al., 1994). The
proteins encoded by these genes vary considerably in size and share little
homology amongst each other or with any other known proteins. They do
however contain a common 14 amino acid motif at the N-terminus, termed
the RHG motif or the IAP-binding motif (IBM) which has been
demonstrated to be critical for their pro-apoptotic function (Wing et al.,
2001) (Fig 1.2).

On the basis of this motif, three other pro-apoptotic
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“reaper-like” genes have been characterized in Drosophila. Sickle (skl) lies
immediately adjacent to the H99 locus and like rpr, is acutely upregulated in
response to certain apoptotic stimuli such as ionizing radiation (Christich et
al., 2002; Srinivasula et al., 2002; Wing et al., 2002). The thioredoxin
peroxidase Jafrac2 is an IBM containing protein that normally resides in the
endoplasmic reticulum of healthy cells, but is rapidly released into the
cytosol following apoptotic stimuli (Tenev et al., 2002).

Finally, as

previously mentioned, a Drosophila homolog of the mammalian
mitochondrial serine protease HtrA2/Omi was recently cloned and
characterized (Igaki et al., 2007). DmHtrA2 is a developmentally regulated
mitochondrial intermembrane space (IMS) protein that undergoes processive
cleavage, in situ, to generate two distinct IBM motifs.

In response to

apoptotic stimuli DmHtrA2 is translocated to the extramitochondrial
compartment in a manner reminiscent of its mammalian homolog and other
pro-apoptotic intermembrane space proteins (Challa et al., 2007). Despite
the virtual lack of homology between RHG proteins outside of the IBM
motif, an abundance of data indicates that, at least in part, they function
mechanistically in a similar fashion by disrupting the function of the same
key regulatory molecule, Diap1. This inhibition of Diap1 function in turn
allows for activation of caspases and engagement of the cell death program.
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Rpr

M A V A F Y I P D Q A T

Hid

M A V P F Y L P E G G A

Grim

M A I A Y F I P D Q A Q

Skl

M A I P F F E E E H A P

----------- ------------------------Smac/Diablo

* A V P I A Q K S E P H

Omi/HtrA2

* A V P S P P P A S P R

Mouse Caspase-9

* A V P Y Q E G P R P L

Human Caspase-9

* A T P F Q E G L R T F

Fig 1.2. The RHG motif is a N-terminal region conserved among the H99
genes (above the dashed line) and to a lesser extent in several mammalian
proteins. The tetrapeptides highlighted in yellow (IBM) are sufficient for
binding to Xiap. The Drosophila RHG domains are located immediately
carboxy-terminal to the initiation methionine, which is presumably removed
by methionine amino peptidase activity in vivo. All mammalian IBMcontaining proteins that have been discovered so far undergo proteolytic
processing to expose the IBM.
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Interestingly, heterologous expression of RHG proteins in mammalian
cells was found to efficiently induce apoptosis in these cells, pointing yet
again to a mechanistic conservation between fly and mammalian cell death
pathways and suggesting the existence of mammalian RHG protein
homologues (Claveria et al., 1998; Haining et al., 1999; McCarthy and Dixit,
1998).

Though no mammalian counterparts with extensive sequence

similarity to any of the Drosophila RHG proteins have been found, three
mammalian proteins have been identified that do contain an N-terminal
RHG tetrapeptide motif and appear to function in part via a molecular
mechanism similar to that of the RHG proteins. Two of these proteins,
Smac/Diablo and HtrA2/Omi, are among the mitochondrial IMS proteins
released into the cytosol in response to apoptotic stimuli whereas the third,
GSPT1/eRF3, is a proteolytically processed isoform of an endoplasmic
reticulum-associated protein whose normal role is to act during translation as
a polypeptide chain release factor (Du et al., 2000; Hegde et al., 2003;
Suzuki et al., 2001a; Verhagen et al., 2000). In addition, recent screens have
identified several other putative molecules that interact with IAPs via Nterminal IAP binding motifs (Verhagen et al., 2007). The validity of these
mammalian IBM containing proteins as bona-fide regulators of apoptosis,
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however, remains controversial and the search for legitimate RHG homologs
is ongoing.

Inhibitor of Apoptosis Proteins (IAPs)
Diap1 belongs to the highly conserved class of cell death suppressors
known as the Inhibitor of Apoptosis Proteins (IAPs). Discovery of this
protein family came from virologists originally studying a mutant form of
the baculovirus Autographa californica nuclear polyhedrosis virus
(AcMNPV) that resulted in premature cell death during infection of
Spodoptera frugiperda (SF-21) insect cells.

Characterization of this

spontaneous viral mutant determined that the baculoviral protein p35 was
responsible for blocking the apoptotic response in the infected host cell
(Clem et al., 1991; Friesen and Miller, 1987). With no homology to proteins
outside of Baculoviridae, p35 was subsequently shown to be a broad caspase
inhibitor in several species and was quickly adopted as an invaluable tool for
apoptosis research (Bump et al., 1995; Xue and Robert Horvitz, 1995). The
only other caspase inhibitor known at the time, cytokine response modifier
A (CrmA), was also discovered by virologists, before caspases were termed
'caspases', and before caspases were known to be the key executioners of the
cell death program (Pickup et al., 1986). Originally identified on the basis
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of its ability to produce hemorrhage in developing chick embryos, CrmA
was determined to efficiently block inflammatory responses by specifically
inhibiting Interleukin-lβ Converting Enzyme (ICE), now known as Caspase1 (Palumbo et al., 1989; Ray et al., 1992). Unlike p35, CrmA contained
extensive homology to other proteins that immediately placed it into the
large and ancient serpin family of serine protease inhibitors. Although they
have no structural similarity, CrmA and p35 both inactivate their cognate
proteases in a mechanism-based manner by behaving as ‘suicide substrates’.
The reactive-site loop of the inhibitor binds to the active site of the caspase
and is cleaved, inducing a conformational change that irreversibly locks the
protease in an inactive conformation (Simonovic et al., 2000; Xu et al.,
2001). It is believed that baculoviruses express these inhibitors to suppress
and escape an apoptotic host response that would otherwise limit viral
replication (Clem and Miller, 1994).
To identify additional genes involved in the inhibition of virally
induced apoptosis, Miller et al. conducted a screen for genes that could
functionally complement for loss of p35.

This approach successfully

identified such a gene from another baculovirus, Cydia pomonella granulosis
virus (CpGV) that could also block actinomycin D induced apoptosis in SF21 cells. Named inhibitor of apoptosis or Cp-iap, this gene remarkably
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turned out to encode a protein with zinc finger motifs (the BIR domains)
homologous to those found in several human proto-oncogenes and insect
embryonic development genes (Crook et al., 1993). Orthologous proteins
that also function as cell death inhibitors have subsequently been identified
in a wide variety of organisms including insects, mammals and plants
making Cp-iap the founding member of an evolutionarily conserved IAP
family of apoptosis inhibitors (Salvesen and Duckett, 2002) (Fig 1.3).
All IAPs are characterized by the presence of between one and three
tandem BIR domains, each approximately 70 amino acids in length and
comprising a zinc-binding fold (Deveraux and Reed, 1999).

The BIR

domains of IAPs are critical for their anti-apoptotic properties and in flies
and mammals, endogenous IAPs can inhibit active caspases by direct
binding of their BIR domains to caspase catalytic sites, by promoting the
degradation of active caspases or by sequestering caspases away from target
substrates (Hinds et al., 1999; Riedl et al., 2001; Tenev et al., 2005). IAPs
exhibit specificity towards a subset of caspases. Mammalian Xiap, Ciap1
and Ciap2, for example, can bind and through diverse mechanisms inhibit
Caspase-3, -7 and -9 but do not interact with Caspase-1, -6, -8 or -10
(Deveraux et al., 1997; Roy et al., 1997). Moreover, the individual BIR
domains of those IAPS with multiple BIR domains, fold into functionally
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independent structures that target and inhibit distinct caspases. Xiap, which
contains three BIR domains, requires the BIR2 domain and a small Nterminal extension of BIR2 for the inhibition of Caspase-3 and -7, whereas
the BIR3 domain of Xiap is essential for the inactivation of Caspase-9 (Chai
et al., 2001; Riedl et al., 2001; Shiozaki et al., 2003).

Similarly in

Drosophila, the BIR1 domain of Diap1 was found to specifically bind the
effector caspases Dcp-1 and Drice, while BIR2 was found to be essential for
binding the initiator caspase Dronc (Meier et al., 2000b; Zachariou et al.,
2003).
Not all BIR containing proteins are IAPs however, as some of these
proteins appear not to function as bona fide inhibitors of apoptosis, but
rather seem to have roles in other vital cellular processes.

C. elegans

encodes two proteins, CeBir1 and CeBir2 that possess BIR domains, but
neither are considered veritable IAPs because they have not been found to
play a role in regulating apoptosis. Instead, CeBir1, it’s yeast homolog
Bir1p and its mammalian homolog Survivin, are primarily involved in
cytokinesis as members of the chromosomal passenger complex (Fraser et
al., 1999; Lens et al., 2006; Li et al., 1998; Rajagopalan and
Balasubramanian, 2002; Speliotes et al., 2000).
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Fig 1.3.

Domain architecture of Drosophila and human IAPs.

The

drosophila genome encodes four IAP genes; the human genome eight. CpIap, the first IAP discovered, is also shown. Current evidence indicates that
only Diap1 and Xiap1 are direct inhibitors of caspase activity. In addition to
at least one baculoviral IAP repeat (BIR) domain, most IAPs have other
distinct functional domains. RING, Really Interesting New Gene; UBC,
Ubiquitin-conjugation;

NACHT,

nucleotide-oligomerization

Numbers to the left indicate the length in amino acid residues.
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domain.

Ring Domains and Ubiquitination
In addition to BIR domains, IAPs with clearly defined roles in
apoptosis also contain a second highly conserved zinc-binding motif at their
carboxyl terminus called the RING domain (for Really Interesting New
Gene.)

The RING domain can behave as an E3 ubiquitin ligase and

functions to recruit E2 ubiquitin-conjugating enzymes to target proteins,
which are subsequently ubiquitylated by the transfer of a 76-amino-acid
ubiquitin peptide (Joazeiro and Weissman, 2000).

In contrast to the

multisubunit RING E3 ligases, IAP E3 ligases combine a substrate-binding
domain (the BIRs) and a RING domain within the same protein. Since
ubiquitylation of proteins has emerged as a fundamental regulatory
mechanism in eukaryotic cells, it follows that ubiquitin-mediated protein
regulation is involved in IAP function.
The importance of the RING domain for the regulation of caspases
and apoptosis in vivo was revealed by Drosophila screens that identified
disruptive point mutations in the diap1 RING that are embryonic lethal (Lisi
et al., 2000; Moore et al., 1998). Contrary to much early in vitro and
overexpression data, in vivo, Diap1 requires not only its BIR2 domain to
bind the initiator caspase Dronc, but also a structurally intact RING domain
to neutralize it (Chai et al., 2003; Wilson et al., 2002). The complexity of
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Diap1 mediated apoptosis control and the critical role of the RING in this
task are further underscored by evidence demonstrating that Diap1 promotes
the ubiquitylation of a number of proteins including Rpr, Hid, Grim,
dTRAF1 and of itself by way of an autoubiquitination reaction (Kuranaga et
al., 2002; Olson et al., 2003; Ryoo et al., 2002). Similarly, Xiap has been
demonstrated to ubiquitinate several proteins in a RING dependent manner
including Smac/Diablo, Caspase-3, Caspase-9, MURR1 (a factor recently
implicated in copper homeostasis), AIF and itself via autoubiquitination
(MacFarlane et al., 2002; Morizane et al., 2005; Suzuki et al., 2001b;
Wilkinson et al., 2007; Yang et al., 2000). Genetic evidence implicating the
Xiap RING domain in apoptosis regulation has recently been furnished by
Schile et al., who generated a knock-in mouse expressing a RING-deleted
Xiap. Mouse embryonic fibroblasts (MEFs) derived from this mouse are
strongly sensitized to TNF-α induced apoptosis. Furthermore, deletion of
the RING in Xiap lessens the incidence of leukemia and prolongs the
survival of mice on a Eu-myc lymphoma background.

The authors

demonstrated using irradiated MEFs that deletion of the Xiap RING domain
results in reduced caspase ubiquitination and concluded that the
ubiquitinating activity of Xiap is important for its role as a negative
regulator of apoptosis (Schile et al., 2008).
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The functional significance of IAP RING-mediated ubiquitylation of
target proteins is often unclear however. In general, a target protein can be
subjected

to

several

possible

ubiquitylation

outcomes

such

as

monoubiquitylation, multi-monoubiquitylation, polyubiquitylation through a
K48 linkage or polyubiquitylation through a non-K48 linkage.

Only

substrates that are polyubiquitylated by a K48-linked chain of four or more
ubiquitins are rapidly recruited to the 26S proteasome and degraded (Vaux
and Silke, 2005). Therefore, even though an important role of the ubiquitin
system is to regulate the half-life of proteins by targeting them for
degradation by the 26S proteasome, there are many ubiquitin modifications
that do not result in protein degradation but instead alter the activity of the
modified protein. A prime example is provided by the regulation of Dronc
by Diap1 in Drosophila. Despite a requirement of the Diap1 RING finger
for Dronc ubiquitylation and the suppression of apoptosis, Diap1 does not
target Dronc for degradation, indicating an inhibitory, but non-degradative,
polyubiquitylation event (Wilson et al., 2002). Similar observations in a
mammalian system suggest a regulatory mechanism involving IAP-mediated
non-degradative mono-ubiquitylation of Caspases-3 and -7 (Huang et al.,
2000). The ubiquitylation of caspases in this manner could, for example,
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suppress them by blocking their recruitment into apoptosome complexes or
modifying their subcellular localization.
Given that ubiquitylation might arguably demonstrate as diverse a
regulatory repertoire as phosphorylation, the regulation of caspases and
other proteins by RING containing IAPs could prove enormously complex.
It has been hypothesized that RING-mediated autoubiquitination of IAPs
leads to their degradation and that this process is a key regulatory event in
the apoptotic program, perhaps illustrating a paradigm in which levels of
IAPs are carefully governed (Ryoo et al., 2002; Yang et al., 2000). Some
recent data suggests however that this may be an oversimplification. In
some contexts, RING-mediated cross ubiquitination by paralogous IAPs
may be required to elicit degradational targeting to the proteasome. Silke et
al. have shown, for example, that mammalian Ciap1 binds directly to Xiap
via a homotypic RING-RING interaction, leading to the ubiquitination and
subsequent proteasomal degradation of Xiap (Silke et al., 2005). It has also
been demonstrated that Ciap2 is a direct target of Ciap1-mediated RINGdependent ubiquitination and degradation (Conze et al., 2005). Similarly,
Herman-Bachinsky et al. have recently provided evidence that the RINGfinger-mediated autoubiquitinating activity of Diap1 does not involve
formation of the Lys48-based polyubiquitin chains necessary for targeting to
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the proteasome, but rather produces chains linked via Lys63 that serve only
to attenuate the ligase activity of Diap1 towards its exogenous substrates.
They argue therefore, that it is Diap2 that ubiquitinates Diap1 with the
Lys48-based polyubiquitin tag required for proteasomal degradation
(Herman-Bachinsky et al., 2007). Despite these interesting observations
however, this scenario seems improbable given that Diap2 null mutant flies,
recently generated by two independent groups, exhibit essentially no
apoptotic phenotype (Huh et al., 2007; Leulier et al., 2006).
It is clear that the RING is an important regulatory domain for IAP
stability but the precise mechanisms and role of this regulation remain
elusive at present. Some authors have questioned the importance of IAP
degradation for apoptosis regulation all together, pointing out that IAPantagonist can inhibit IAPs and promote caspase activation irrespective of
whether or not IAPs are degraded (Ditzel and Meier, 2002). These authors
suggest that Diap1 degradation is not a decisive event in the initiation of
apoptosis, but rather a method to destroy low levels of unscheduled IBM
protein production in healthy non-apoptotic cells. Further study of IAPs and
their interacting proteins is required to clarify the role of RING domains in
apoptosis regulation.
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Mechanisms of IAP Mediated Caspase Inhibition
Of the eight known human BIR containing proteins, current data
indicates that Xiap may actually be the only bona fide caspase inhibitor.
Xiap is a 497-amino acid polypeptide with a predicted mass of 57 kD that is
ubiquitously expressed in human tissues. It has been the most intensely
studied IAP and is also the most potent inhibitor of cell death in vitro
(Duckett et al., 1996; Holcik et al., 2001; Listen et al., 1996). Given the
high sequence and domain conservation amongst IAPs, it had been assumed
that they all neutralize active caspases through the same BIR-dependent
mechanism. Though there are indeed conserved aspects of this mechanism,
recent biochemical and structural studies have precisely mapped the
elements of Xiap required for caspase inhibition and surprisingly some of
these elements are not conserved among IAPs.

This has precluded a

universal mechanism of inhibition by this protein family and it is now
appreciated that IAPs can inhibit caspases and apoptosis through a variety of
distinct mechanisms (Tenev et al., 2005).
Employing a unique strategy, which differs from that described
previously for viral caspase inhibitors, both the BIR2 and BIR3 domains of
Xiap use a two-site binding mechanism for potent inhibition of their
respective caspases.

One binding site is a conserved surface groove
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characteristic of many BIR domains that has a preference for binding the
extreme N terminus of short peptides of defined sequence. The peptide
sequence preferred by BIR domains, AXPX where X represents a
hydrophobic amino acid, is termed the IAP-binding motif (IBM) (Shi,
2002).

Activation of Caspase-3, Caspase-7 and Caspase-9 involves

proteolytic processing that generates such an IBM in the small-subunit
amino terminus of the caspase and crystal structures have confirmed that
Xiap BIR domains bind to this IBM via its conserved IBM-interacting
surface groove. This conserved interaction surface of Xiap, referred to as an
exosite-anchoring motif is not sufficient for potent caspase inhibition
however. A second non-conserved interaction between Xiap and caspases is
required. For inhibition of effector Caspases-3 and 7 by BIR2, residues
directly preceding the BIR2 domain provide such an interaction.

This

peptide loop stretches across the catalytic-binding cleft of the caspase in a
reverse orientation relative to that of a substrate protein thereby generating a
steric blockade prohibitive of substrate binding (Chai et al., 2001; Huang et
al., 2001; Riedl et al., 2001). This unusual reverse-binding mechanism had
previously been described for members of the papain family of proteases
which use their own amino terminal prosegment to inhibit their enzyme
activity (Coulombe et al., 1996). In the case of Caspase-9, rather than
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targeting the enzyme active site directly, the BIR3 domain of Xiap abolishes
activity using a fundamentally different mechanism. Structural analysis of a
BIR3/Caspase-9 complex has revealed that a helix found immediately after
the BIR3 domain packs against the dimer interface of Caspase-9,
sequestering Caspase-9 in a monomeric state and forcing the protease into a
dormant conformation with a collapsed active site (Shiozaki et al., 2003).
Xiap is the first example of a natural protease inhibitor that uses this kind of
allosteric mechanism (Eckelman et al., 2006).
The closest paralogues of Xiap, Ciap1 and Ciap2, also contain three
BIR domains and a RING domain and similar to Xiap, Ciap overexpression
protects cells from apoptosis (Listen et al., 1996; Uren et al., 1996). Ciap1
and Ciap2 also contain a CARD domain and were originally identified
through their ability to interact directly with the TNF receptor-associated
factor TRAF2 (Rothe et al., 1995). The BIR domains of Ciaps contain IBMinteracting grooves that are highly conserved with those in Xiap and Ciaps
can bind caspases in vitro. However critical residues surrounding the BIR
domains as revealed by the crystal structures of Xiap are not conserved in
Ciaps and as a consequence they are incapable of directly inhibiting the
enzymatic activity of caspases (Eckelman and Salvesen, 2006). On the basis
of these structural arguments, it is probable that the other human BIR-

41

containing proteins, ML-Iap, Ilp2, Naip, Survivin and Bruce are not direct
caspase inhibitors either. In several instances this has been demonstrated.
Vucic and colleagues showed that ML-Iap is not a tight inhibitor of Caspase9, Shin and colleagues have shown that Ilp2 cannot inhibit Caspase 9 in a
physiological way on its own and Survivin is now thought to primarily be a
regulator of the mitotic spindle (Lens et al., 2006; Shin et al., 2005; Vucic et
al., 2005). Earlier studies concluding that IAPs other than Xiap were direct
caspase inhibitors have largely been revised in light of problematic
experimental techniques, principally concerning the use of GST tags.
The mechanisms by which Ciaps and other mammalian IAPs
attenuate apoptosis possibly include: binding to IAP antagonists to reduce
the amount available to antagonize Xiap, influencing signaling by NF-κB
and MAP kinases, or targeting caspases for ubiquitylation and proteasomal
degradation (Tenev et al., 2005). For example, through TRAF2 interactions,
Ciaps are recruited to TNFR1 and TNFR2 associated complexes where they
regulate receptor-mediated apoptosis via modulation of NF-κB activity and
suppression of Caspase-8 activation (Micheau and Tschopp, 2003a; Shu et
al., 1996; Wang et al., 1998). This interaction is conferred by the first two
alpha-helices in the BIR1 domain of Ciap1 and Ciap2 (Samuel et al., 2006).
Engagement of TNFR2 by TNF-α results in TRAF2 ubiquitination in a
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manner that depends on the RING domain of Ciap1 (Li et al., 2002). Ciap1
and Ciap2 also promote proteasomal degradation of NF-κB inducing kinase
(NIK), a highly labile ser/thr kinase that is a critical regulator of the
noncanonical NF-κB pathway (Varfolomeev et al., 2007). Similarly, Xiap
has been demonstrated to induce NF-κB and MAP kinase activation in a
BIR1 dependent manner during TGF-ß and BMP receptor signaling through
engagement of the NF-κB regulator TAB1 (Lu et al., 2007). Xiap has also
recently been shown to directly bind copper and to be involved in copper
homeostasis (Mufti et al., 2006). It is clear from these and other studies that
IAPs are complex molecules with the capability to impinge on cell survival
at multiple points in various signaling pathways.
Since knockout studies of mammalian IAPs (Xiap,Ciap1 and Ciap2)
have failed to reveal significant apoptosis phenotypes, possibly due to
redundancy or compensatory mechanisms, the strongest in vivo evidence for
a direct role of IAPs in the regulation of caspases and apoptosis comes from
genetic studies in the fruit fly (Conte et al., 2006; Conze et al., 2005; Harlin
et al., 2001). Drosophila contains four IAPs of which Diap1 appears to be
the most critical.

Genetic loss of diap1 leads to uncontrolled caspase

activation, resulting in premature and widespread unscheduled apoptosis
which culminates in embryonic lethality (Goyal et al., 2000; Wang et al.,
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1999). This suggests that diap1 provides an essential requirement for the
inhibition of apoptosis and is consistent with the fact that diap1 has been
shown to directly interact with at least three Drosophila caspases, the apical
caspase Dronc and the effector caspases Drice and Dcp-1 (Meier et al.,
2000b; Zachariou et al., 2003).
In contrast to Xiap, structural data for Diap1, which contains only two
BIRs and a RING, is limited to complexes containing the BIR1 domain
bound to a ten-residue peptide derived from the N terminus of Rpr or Grim,
and the BIR2 domain alone or bound to a ten-residue peptide derived from
the N-terminus of Hid or Grim. In addition, the BIR2 domain of Diap1 has
been crystallized with residues 114-123 of the initiator caspase Dronc.
These structures reveal that the Diap1 BIR motifs contain the same
conserved IBM-interacting surface groove found in Xiap and that this pocket
is the site for mutually exclusive contact between caspases and the RHG
proteins. In a manner reminiscent of Xiap, Diap1 requires non-conserved
residues adjacent to its BIR1 domain to efficiently bind caspases.
Biochemical data indicate that the BIR1 domain and the adjacent carboxyterminal linker region of Diap1 are necessary and sufficient for direct
inhibition of the effector caspases Drice and Dcp-1 (Tenev et al., 2005; Yan
et al., 2004). Due to a lack of structural information for Diap1 complexes,
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the precise molecular mechanism of this inhibition remains unknown. It
may be that Xiap and processed Diap1 use a similar two-site binding
strategy for potent inhibition of effector caspases, both using a BIR domain
as a platform to correctly deploy an adjacent inhibitory peptide.
The mechanism for inhibition of the initiator caspase Dronc by Diap1,
however, is completely distinct from that of Xiap mediated caspase-9
inhibition. First, Diap1 binds Dronc not via an N-terminal IBM motif, but
through a 12 amino acid fragment between the CARD and the protease
domain of Dronc (Chai et al., 2003). Consequently, Diap1 is uniquely able
to bind both active Dronc and the unprocessed Dronc zymogen. Secondly,
Diap1 does not directly inhibit Dronc activity, but rather regulates the
activity of Dronc through a mechanism that is dependent on its RING finger.
Strong in vivo evidence has demonstrated that the E3 ubiquitin ligase
activity of Diap1 is required for Dronc ubiquitination and is indispensable
for Dronc inhibition and apoptosis regulation (Wilson et al., 2002).
The activity of Diap1 itself may be regulated in several ways not yet
observed for mammalian IAPs. Diap1 contains an N-terminal fragment that
some authors believe is autoinhibitory and must first be cleaved before
Diap1 can interact with and inhibit effector caspases. According to this
model, cleavage of the N-terminus not only renders Diap1 competent for
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caspase binding, but it also converts Diap1 into a highly unstable, Asnbearing N-degron of the N-end rule degradation pathway that is rapidly
degraded (Ditzel et al., 2003).
Far less is known about the other Drosophila IAPs, Diap2, dBruce
and Deterin and evidence implicating these genes in apoptosis is largely
limited to overexpression studies (Hay et al., 1995; Jones et al., 2000;
Vernooy et al., 2002). Dbruce is the Drosophila ortholog of the mouse
bruce and human apollon genes and is predicted to encode an enormous
protein of 4852 amino acids with an N-terminal BIR domain and a Cterminal ubiquitin conjugation (UBC) domain. Some in vivo data supporting
a role for dBruce as an apoptotic regulator has come from genetic screens
designed to identify components of the rpr and hid apoptotic pathways.
These screens isolated 11 loss-of-function alleles of dbruce that enhance
rpr- and grim- but not hid-induced cell death and one gain-of-function allele
that suppresses hid- but not rpr- or grim-induced death (Agapite, 2002).
This differential pattern of enhancement and suppression is highly
reminiscent of that observed for Diap1 mutants, raising the intriguing
possibility that perhaps Dbruce and Diap1 function together in an E2/E3
complex to ubiquitinate target proteins. Unlike Diap1 however, dBruce null
mutants are male sterile but viable, indicating that dBbruce has a more
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restricted role than Diap1 during development. Intriguingly, dBruce has
recently been shown to bind Klh10, a component of the testis-specific
Cullin-3-Roc1b-dependent ubiquitin ligase complex that is required for
caspase activation in spermatids (Arama et al., 2007). This interaction led
the authors to speculate that dBruce may be the IAP that spatially and
temporally restricts caspase activation during sperm differentiation and that
the Cullin-3 enzyme complex activates caspases by degrading dBruce in
response to developmental cues.
The physiological function of Diap2 has been investigated recently by
two groups that generated diap2 null alleles (Huh et al., 2007; Leulier et al.,
2006). Diap2 mutant animals develop normally, are fully viable and show
no defects in developmental or stress-induced apoptosis, suggesting that
diap2 is dispensable for cell survival.

Instead, diap2 was found to be

essential for the innate immune response to Gram-negative bacterial
infection. Drosophila melanogaster lacks an adaptive immune system and
relies exclusively on innate immune reactions for its defense against
microbial infection. The immune deficiency (Imd) signaling pathway is
activated in response to gram-negative bacteria and triggers nuclear
translocation of the NF-κB like transcription factor Relish, which in turn
induces expression of antibacterial genes (Hoffmann, 2003). Loss of Diap2
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results in a profound defect in Relish nuclear translocation and antimicrobial
peptide (AMP) expression, rendering mutant flies acutely sensitive to
infection by gram-negative bacteria.

These results suggest that Diap2, like

the Ciaps in mammals, may function as an E3 ubiquitin ligase in a receptor
signaling cascade rather than as an inhibitor of caspase activation.

The MAPK Pathway and Apoptosis
Cell survival is regulated by a multitude of extracellular and
intracellular signals and in most tissues, suppression of apoptosis is
dependent upon a constant supply of exogenous survival signals. These
signals are furnished by neighboring cells and the extracellular matrix as
either immobilized or soluble peptide factors (Raff, 1992). Growth factors
such as fibroblast growth factor (FGF) and epidermal growth factor (EGF)
are classic examples of survival factors that inactivate the intrinsic cell death
program, thereby promoting cell survival. These growth factors bind to and
activate receptor tyrosine kinases (RTKs), such as the EGF receptor
(EGFR), at the cell surface and initiate a survival signal that is propagated
throughout the cell via a number of effector pathways (Downward, 1998)
(Fig 1.4). The mitogen-activated protein kinase (MAPK) cascade is one
such effector pathway that responds to extracellular cues and transduces
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signals from the cell surface to the nucleus via a protein phosphorelay
system consisting of three sequentially activated kinases. This succession of
kinases provides a signaling framework that is amenable to feedback
regulation and signal amplification (Fig. 1.4).
MAPK signaling cascades are known to modulate a number of critical
cellular activities including gene expression, mitosis, proliferation, motility,
metabolism and programmed cell death (Johnson and Lapadat, 2002).
Among the three subfamilies of MAPK modules

that have been well

characterized in multicellular organisms, it is the extracellular signalregulated kinase (ERK) branch which has been implicated in promoting cell
survival (Wada and Penninger, 2004). The canonical ERK-MAPK module
consists of three successive serine/threonine kinases; Raf, MEK and ERK.
Once activated, Raf initiates a phosphorylation cascade, whereby Raf
phosphorylates and activates MEK, and MEK in turn phosphorylates and
activates ERK.

Activated ERKs then phosphorylate and regulate the

activities more than 160 proteins, the majority of which are nuclear proteins,
including several transcription factors such as c-Myc, Elk-1 and Ets-2 (Yoon
and Seger, 2006). A central regulator of this signal transduction relay is the
small GTPase Ras, which acts as a molecular switch in response to RTK
activity to directly control the activity of Raf and therefore the MAPK
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Fig 1.4. The RTK/Ras/MAPK signaling pathway. This illustration of the
canonical MAPK signaling pathway highlights regulatory components that
are conserved between humans and flies. Conserved RTK subfamilies that
are known to employ canonical MAPK signaling include the Egfr, Fgfr,
Pdgfr, Insr, Vegfr, Alk, Eph, Ret and Tie receptor subfamilies. Different
receptors use various combinations of adaptor (Shc) and docking proteins
such as Irs1 (Dme: Chico) to recruit Grb2 (Dme: Drk) and Sos to ligand
activated receptor complexes. Sos catalyzes nucleotide exchange on RasGDP converting it to its active Ras-GTP form. Active Ras engages several
downstream signaling molecules including the MAPKKK, Raf (Dme: Pole
hole, Phl) and PI3-Kinase (Dme: PI3K92E/Dp110).

Active Raf in turn

phosphorylates and activates MEK (Dme: Dsor1), which phosphorylates and
activates ERK (Dme: Rolled, rl). KSR and 14-3-3 (Dme: leonardo) are
scaffolding proteins that facilitate Ras-dependent ERK cascade activation at
the plasma membrane. Once active, ERK phosphorylates a large number of
substrates including Ribosomal Protein S6 Kinase (RSK) in the cytosol and
a number of transcription factors in the nucleus, including the activator Ets1
(Dme: Pointed, Pnt) and the repressor Tel1 (Dme: Yan). GTPase-activating
proteins (GAPs) such as RasA3 (Dme: Gap1) and Nf1 terminate Ras
signaling by accelerating the conversion of Ras-GTP to its inactive RasGDP form. Active Ras is also antagonized by Sprouty (Spry) proteins and
active ERK is inactivated by the Ser/Thr phosphatase PP2A (Dme:
Microtubule Star, Mts). PTP, protein tyrosine phosphatase. Dme above
refers to the drosophila homolog if the component name is different than its
mammalian counterpart.
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module. Recently, a number of ERK scaffolding proteins and signaling
modulators have also been identified that play critical roles in determining
the strength, duration and location of MAPK signaling (Fig 1.4). Together,
these factors contribute to the diversity of biological responses generated by
the RTK/MAPK signaling axis (McKay and Morrison, 2007).
Given the critical involvement of the ERK-MAPK module in
transmitting cell proliferation and anti-apoptotic signals, the overwhelming
frequency in which this pathway is aberrantly activated in human cancer is
perhaps not too surprising.

Studies using genetic or pharmacologic

approaches have shown that the ERK-MAPK signaling cascade is required
for the transforming activities of Ras, the most frequently mutated oncogene
in human cancers, as well as for tumorigenesis associated with mutationally
activated and/or overexpressed EGFR. Moreover, mutationally activated
Raf has been identified in a considerable fraction and variety of human
tumours (Davies et al., 2002). These observations suggest a critical role for
MAPK activation in oncogenesis, making it an appealing pathway for drug
development.

This has stimulated intensive efforts by the research

community and pharmaceutical industry to develop inhibitors of ERKMAPK signaling for cancer treatment (McCubrey et al., 2007).
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The MAPK signalling pathways are now understood in great detail at
the molecular level as a result of two decades of intense study employing
genetics, molecular and cellular biology, and encompassing organisms from
yeast to man (Fig 1.4).

Indeed, the Drosophila EGFR/MAPK pathway

provides one of the best-characterised examples of a signaling cascade
currently known. The high degree of homology between components of the
Drosophila and mammalian MAPK signaling pathways has permitted many
unique insights derived from examination of this pathway in Drosophila to
be extrapolated to vertebrate systems. For example, the Sprouty (Spry)
family of proteins is a highly conserved group of negative feedback loop
modulators of MAPK activation that was originally discovered in
Drosophila. Four mammalian orthologs of Spry have subesequently been
identified (Hanafusa et al., 2002).
As in mammalian systems, the Drosophila ERK-MAPK module
mediates a plethora of cellular functions during development, including
proliferation, survival, cell fate choice and differentiation.

Though

activation of ERK-MAPK is has long been known to protect cells from
apoptosis by suppressing the intrinsic cell death program, the molecular
mechanisms by which this occurs remain poorly understood. New insights
into understanding the regulation of apoptosis by survival signaling
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pathways, however, has recently come from several genetic screens
conducted in Drosophila, two of which are described in the next chapter.
These studies revealed that activation of MAPK signaling inhibits the
proapoptotic activity of the cell death inducer, hid, both by direct
phosphorylation of the Hid protein and by downregulation of hid mRNA
expression. This defines a novel mechanism by which MAPK signaling
inactivates a critical component of the apoptotic machinery (Bergmann et
al., 1998; Kurada and White, 1998).
It is now exceedingly clear that apoptosis and its regulation are highly
relevant to many human diseases. Genetic lesions leading to diminished
apoptosis play a general role in tumorigenesis and many cancer therapies
result in elevated levels of cancer cell apoptosis (Ziegler and Kung, 2008).
Over the course of the last two decades, many apoptosis effector
mechanisms have been extensively characterized, allowing for the
construction of elegant molecular models to explain the regulation of
apoptosis (Fig 1.5). Nevertheless, our understanding of the pathways that
signal and control developmental cell death is far from complete. Caspases
have taken a leading role as key regulators of apoptosis, but caspase
activation is not synonymous with cell death. A growing appreciation for
the non-apoptotic roles of caspases in a number of critical cellular processes
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such as differentiation, proliferation and cell migration is driving current
efforts to understand how caspase activity is regulated and integrated to
achieve these varied outcomes (Kuranaga and Miura, 2007).

How, for

example, is the extent of caspase activation within a cell temporally and
spatially modulated to permit such specialized feats as dendritic pruning and
spermatid individualization without eliciting self destruction (Arama et al.,
2003; Kuo et al., 2006)? In general, we still do not understand very well
how a particular cell chooses between life and death during development or
disease, but it is clear that a multitude of distinct mechanisms are used to
tightly regulate this decision. Examples for which some insight into the
regulation of apoptosis has been garnered include; the transcriptional
modulation of cell death proteins such as egl-1, activation of caspases by
oligomeric complex formation, inhibition and degradation of caspases by
IAPs and the ubiquitin–proteasome system, activation of caspases through
inhibition of IAPs by RHG proteins and regulation of core cell death
proteins by phosphorylation, microRNAs and modulation of subcellular
localization (Domingos and Steller, 2007).

Finally, recent evidence

indicates that apoptotic cells themselves actively communicate with their
cellular environment to stimulate cell proliferation and tissue regeneration in
a process known as compensatory proliferation (Ryoo et al., 2004).
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The aim of the research presented here was to use genetic and
biochemical approaches in Drosophila to further elucidate the molecular
mechanisms regulating the core, evolutionarily conserved caspase-dependent
cell death pathway.

Towards this end, we present here the partial

characterization of a novel CARD containing serine/threonine kinase as
putative regulator of apotosis and in addition we describe the identification
and characterization of the first endogenous gain-of-function mutation in
Drosophila ras1. We demonstrate biochemically that this mutant produces a
Ras protein with deficient GTPase activity and therefore an enhanced
signaling capacity.

The phenotypic consequence of this in various

developmental contexts is investigated.
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Fig 1.5. The “Gas and Break” model of intrinsic apoptosis control. The
central components of the execution phase of apoptosis in worms, flies and
mammals are members of the caspase protease family. In C. elegans the
adaptor Ced-4 promotes activation of the caspase Ced-3. As in mammals,
upstream decisions are integrated by pro- and anti-apoptotic Bcl-2 protein
family members. In mammals and flies, two fundamental control points
regulate caspase activation.

The figure highlights the forward drive for

zymogen activation by oligomerization of initiator caspases within the
apoptosome (the Gas) and the inhibition of active caspases by IAPs (the
Brakes). IAPs can be derepressed to release caspase activity by species
specific IAP antagonists such as RHG proteins in flies or intermembrane
space mitochondrial proteins discharged into the cytosol in mammals.
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CHAPTER 2.
Preliminary Characterizations of the GMR-hid Suppressor Su(21-3s)
and the Predicted Ser/Thr Kinase CG11870

The work presented in this chapter was built upon the efforts of Julie
Agapite, Kim McCall, Chris Hynds and Andreas Bergmann who conducted
the genetic screen from which the Su(21-3s) mutant is originally derived.
All other data presented here represents original work.
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Summary
In Drosophila melanogaster, the induction of apoptosis requires the activity
of three closely related genes, reaper (rpr), head involution defective (hid),
and grim. The proteins encoded by these genes induce apoptosis in part by
inhibiting the anti-apoptotic activity of the caspase suppressor Diap1 and
lead to activation of an evolutionarily conserved cell death pathway.
Ectopic expression of rpr, hid or grim in the developing Drosophila eye
elicits apoptosis and gives rise to a reduced eye phenotype. Genetic screens
designed to isolate modifiers of this phenotype have been extremely
successful at identifying genes that regulate apoptosis. In one such screen, a
mutant, denoted Su(21-3s), was recovered as a potent dominant suppressor
of hid induced phenotypes. We sought to further characterize this mutant
and to identify the affected gene. Preliminary data pointed to the unknown
gene CG11870, predicted to encode a protein Ser/Thr kinase which,
interestingly, is also reported to contain a putative caspase recruitment
domain (CARD). Our analysis, reported here, reveals that the Su(21-3s)
suppressor phenotype is most likely not due to a mutation in CG11870.
Nevertheless, our partial characterization of this novel CARD containing
kinase exposed a possible interaction with the hid cell death pathway.
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Introduction
Programmed cell death is a fundamental aspect of metazoan
development. Regulated cell death allows an organism to tightly control cell
numbers and tissue size, and to protect itself from rogue cells that threaten
homeostasis (Hengartner 2000). For example, apoptosis, a morphologically
distinct and commonly observed form of programmed cell death, is used
defensively by organisms to eliminate cells infected by viruses, cells
undergoing unregulated proliferation and auto-reactive lymphocytes.
Many of the cellular changes associated with apoptosis are due to the
actions of an evolutionarily conserved family of cysteinyl proteases termed
caspases (Thornberry and Lazebnik 1998).

The critical importance of

caspases in the execution of apoptosis was initially revealed by the discovery
that the C. elegans cell death gene ced-3 encodes a protein similar to the
mammalian caspase, Interleukin-1β-converting enzyme (ICE) (Yuan 1993.)
This family of proteases has since grown to include 11 members in humans,
10 in mice, 7 in Drosophila and 4 in C. elegans (Aravind 2001, Shaham
1998.) Caspases are initially synthesized as inactive (or weakly active)
zymogens, the activation of which is tightly regulated by both positive and
negative inputs (Danial and Korsmeyer, 2004).
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Caspases can broadly be separated into the initiator caspase group and
the effector caspase group on the basis of domain architecture and
physiologic function (Lincz 1998).

Effector caspases contain a short

prodomain, are activated by proteolytic cleavage and are thought to act
downstream of initiator caspases to execute the cell death process by
cleaving a large number of cellular proteins. In contrast, initiator caspases
contain long prodomains that harbor regulatory motifs such as the caspase
recruitment domain (CARD), are activated by an induced-proximity
mechanism following recruitment into oligomeric complexes and are
thought to act further upstream by cleaving a relatively limited number of
substrates (Degterev et al., 2003).
The activity of caspases is negatively regulated by a second highly
conserved class of proteins with members in all eukaryotic species, termed
inhibitor of apoptosis proteins (IAPs) (Crook et al., 1993). Inhibition of
caspases by IAPs is achieved through a number of diverse mechanisms
including direct binding of IAPs to caspase catalytic sites and by targeting
caspases for ubiquitinylation and proteasomal degradation (Tenev et al.,
2005).

Compelling in vivo evidence substantiating a role for IAPs in

apoptosis regulation has come from genetic studies in Drosophila which
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revealed that loss of diap1 leads to uncontrolled caspase activation and
widespread induction of apoptosis (Goyal et al., 2000; Wang et al., 1999).
Genetic analysis of programmed cell death in Drosophila also led to
the discovery of three closely linked genes, rpr, grim and hid, whose gene
products are required for the activation of developmental cell death that
normally occurs during embryogenesis as well as the ectopic death induced
by x-rays or developmental abnormalities (Chen et al., 1996; Grether et al.,
1995; White et al., 1994). Although the proteins encoded by these genes do
not show significant homology to each other or other known proteins, they
do share a conserved 14 amino acid stretch at their N-termini (Chen 1996.)
This conserved sequence, termed the RHG motif, has been shown in a
number of paradigms to induce caspase dependent apoptosis in part by
interacting with and inhibiting Diap1 (Vucic 1998, McCarthy and Dixit
1998, Vucic 1998).
To further define the mechanisms by which rpr, hid and grim activate
caspases and induce cell death, Agapite et al. conducted a genetic screen in
Drosophila to isolate dominant modifiers of hid and rpr induced eye
phenotypes (Agapite, 2002). Approximately 500,000 flies were screened
and 167 dominant modifiers recovered. Among these were components of
the Ras/MAPK pathway and both gain and loss of function alleles of diap1
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and dbruce. One mutant, designated Su(21-3s), was recovered as a strong
dominant suppressor of hid induced phenotypes.

Contrary to what was

initially reported in the screen, our analysis here found Su(21-3s) flies to be
homozygous male and female sterile. Preliminary characterization of this
mutant also identified a polymorphism in the previously uncharacterized
gene CG11870, predicted to encode a putative CARD containing Ser/Thr
kinase. Given the known role of CARD domains in caspase regulation, we
sought to further characterize CG11870 with the aim of identifying a novel
regulatory element in apoptosis.

We have since determined that the

suppressor phenotype of Su(21-3s) does not map to CG11870 but
nevertheless present an initial characterization of this predicted kinase and
present evidence that CG11870 may in some contexts negatively regulate
hid induced apoptosis.

Results
Recovery of Su(21-3s) as a dominant suppressor of GMR-hid induced
apoptosis
Eye-specific expression of hid or rpr under control of the GMR
promoter induces apoptosis and results in a dosage sensitive eye ablation
phenotype (Grether et al., 1995). Dominant modifier screens are designed to
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detect pathway components for which small perturbations in gene dosage
can alter such a sensitized phenotype. This strategy allows for the recovery
of both loss-of-function and gain-of-function mutations and provides a facile
method for screening a large number of genomes. This approach has been
successful in defining a genetic pathway for R7 cell fate determination and
identifying several core cell death genes (Dickson et al., 1996; Hay et al.,
1995; Rebay et al., 2000; Simon et al., 1991).
The Su(21-3s) mutation was originally isolated in mutagenesis screens
conducted by Agapite et al. as described in Fig. 1. The results are briefly
summarized below for reference and presented in Tables 1 and 2 (Agapite,
2002).
Approximately 170,000 F1 progeny of ENU and EMS mutagenized
GMR-rpr flies were screened for dominant modifiers of the rough eye
phenotype leading to the recovery of 25 enhancers and 5 suppressors (Table
1).

Similarly, about 300,000 F1 progeny of ENU, EMS and x-ray

mutagenized flies were screened for suppression of the GMR-hid phenotype
with the recovery of 128 dominant suppressors (Table 2). In sum total, 158
dominant modifiers were identified in these screens.
Modifiers were mapped by segregation, balanced and recessive
phenotypes were assessed. Additionally, modifiers on the 3rd chromosome
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Fig. 2.1. Scheme for the dominant modifier screens conducted by Agapite et
al. (A) GMR-rpr screen. yw; GMR-rpr81 homozygous males were fed either
0.25mg/ml ENU or 25 mM EMS.

F1 progeny, were screened for

suppression or enhancement of the parental rough eye phenotype. Of the
170,000 F1 progeny screened, ~95% derived from ENU treated males, (B)
GMR-hid screen. yw males were treated as above or with 4500 rad x-rays
and then crossed to GMR-hid10 homozygous females. F1 progeny were
screened for suppression of the GMR-hid10 rough eye phenotype. Of the
300,000 F1 progeny screened, ~49% derived from EMS treated males,
~49% from x-ray treated males and 2% from ENU treated males.
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Table 1. GMRrpr modifiers: Summary of genetic interactions
Groups
Star
GMRrpr81
diap1
dBruce
Delta
Other

Map
pos.

No. of
alleles
13-2e
21E4
4
2
11-1e
7-2s
6-3s
72D1
11-3e
10
86A7
2-3e
92A1 10-12e
-th-st5
sr-e
5-2s
sr-e
5-4e

PhenoGMRGMR-rpr GMR-hid
type
grim
SemLth
Enh
ND
ND
Lethal
Enh
ND
ND
Viable
Sup
ND
ND
Rep
Enh
ND
ND
Lethal
Sup
ND
ND
Viable
Sup
Sup
ND
Lethal
Enh
Enh
Enh
Mst
Enh
-Enh
Lethal
Enh
-Enh
Lethal
Enh
Enh
Enh
Viable
Enh
-Enh
Viable
Sup
Sup
ND
Viable
Enh
Enh
Enh

GMRrho1
ND
ND
ND
ND
ND
ND
---Enh
-ND
Enh

GMRphyl
ND
ND
ND
ND
ND
----Enh
-Sup
Lethal

Complementation groups are named for the known gene to which they
correspond. The group named “other” consists of mutants that could not be
placed into a complementation group. -th-st- indicates that the mutation was
roughly mapped by meiotic recombination around the markers th and st and
may be located on either side, whereas sr-e indicates that the mutation maps
between sr and e.

Alleles with the same map position and similar

phenotypes are grouped together for simplicity. Single alleles are named.
Sup, suppressor; Enh, enhancer; --, no effect; ND, not done; Mst, male
sterile; SemLth, semi lethal.
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Table 2. GMR-hid suppressors: Summary of genetic interactions
Groups

sprouty

Gap1

diap1

Su(GMRhid)
2A

Su(GMR)2A
dBruce
glass
Su(GMRhid)
3A

Su(GMRhid)
3B

Su(GMR)3A

Map
Alleles
pos.
23-14s
25-1s
63D2 27-1s
28-4s
30-5s
21-1s
22-2s
67C10 23-9s
24-6s
26-2s
21-2s
21-4s
22-8s
23-4s
72D1
23-8s
33-1s
41-8s
45-2s
26-3s
nd
2
32-1s
43-4s
22-1s
27-2s
2nd0
29-4s
30-2s
86A7 23-6s
91A3 23-3s
sr-e 23-15s
3rd
29-2s
sr-e 24-3s
3rd
38-5s
-sr38-7s
sr-e 38-8s
-sr-e- 38-11s
-sr- 38-13s
sr-e 40-4s
3rd
40-6s
24-9s
28-1s
3rd
30-6s
32-3s

Pheno- GMR- GMRtype
rpr
grim
Lethal
Sup
Sup
Lethal
Sup
ND
Lethal
Sup
Sup
Lethal
Sup
Sup
Lethal
Sup
Sup
Ro, wv
WS
Sup
Ro, wv
WS
Sup
Ro, wv
ND
ND
Ro, wv
WS
Sup
Ro, wv
Sup
Sup
SemLth Sup
Sup
Lethal
Enh
ND
Lethal
Enh
Enh
Lethal
Sup
Sup
Lethal
Sup
Sup
Lethal
Enh
Enh
Lethal
Enh
ND
SemLth Sup
ND
Lethal
Sup
ND
Lethal
Sup
ND
Lethal
ND
ND
Lethal
Sup
ND
Lethal
Sup
ND
Lethal
Sup
ND
Lethal
Sup
ND
Lethal
Enh
Enh
Ro
Sup
Sup
Lethal
Sup
Sup
Lethal
Sup
ND
Rep, ro
Sup
ND
Rep, ro
Sup
ND
Rep, ro
Sup
ND
Rep, ro
ND
ND
Rep, ro
Sup
ND
Rep, ro
Sup
ND
Rep, ro
Sup
ND
Rep, ro
Sup
ND
Lethal
Sup
ND
Lethal
Sup
ND
Lethal
Sup
Sup
Lethal
Sup
Sup
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GMRvg-//
hs-hid
phyl
hid
-Sup
--Sup
-W.su Sup ND
W.su Sup
-W.su
ND
--Sup
--Sup
-ND
Sup
-W.su Sup
--Sup
--Sup Sup
-Sup Sup
ND
Sup
-W.su Sup Sup
-Sup Sup
W.en Sup Sup
-Sup ND
ND
ND Sup
ND
ND
ND
ND
ND
ND
ND
ND
ND
WS
ND
ND
WS
ND
ND
-ND
ND
Sup
ND
ND
W.en Sup Sup
Sup
--W.su Sup Sup
Sup
ND
-WS
Sup
-ND
ND
-Sup
ND
-Sup
ND
-Sup
--Sup
ND
-ND
ND
-Sup
ND
-W.su
-ND
W.su
--Lethal ND
ND
Sup
ND
ND

Table 2. GMR-hid suppressors: Summary of genetic interactions

Other

-th-stth-stst-cu
-cu-cucu-sr
-sr-sr-sr-srsr-e
sr-e
sr-e
sr-e
sr-e
sr-e
sr-e
sr-e

32-8s Lethal
24-4s Viable
41-1s Viable
27-17s Lethal
21-3s Viable
39-1s
Ro
23-5s Lethal
22-6s
Wv
24-8s Viable
30-4s Viable
41-4s
Ro
24-2s Rep, ro
28-7s Rep, ro
40-5s Lethal
41-2s Lethal
41-6s
Ro
41-7s Lethal
43-1s
Wv
43-5s Rep, ro

Sup
ND
ND
ND
Sup
Sup
Sup
Sup
Sup
ND
ND
Sup
Sup
Sup
Sup
Sup
Sup
ND
ND

Sup
ND
ND
Sup
Sup
ND
Sup
ND
ND
ND
ND
ND
ND
Sup
Sup
ND
Sup
ND
ND

Sup
ND
ND
ND
--W.su
Sup
W.su
ND
ND
Sup
Sup
-Sup
Sup
Sup
ND
ND

W.su ND
Sup
-ND
-W.su ND
Sup Sup
Sup
-W.su W.su
Sup
-Sup
-ND
-ND
-W.su
-Sup
-W.su Sup
ND Sup
ND
-ND Sup
ND
-ND
--

Legend is as for Table 1. -th-st-, -cu- and -sr- indicate that the mutation
maps around the designated markers and may be located on either side. stcu, cu-sr and sr-e indicate that the mutation maps between the designated
markers. The mutation characterized in this study, su(21-3s), is highlighted
in yellow. Rep, reduced eye pigmentation; Ro, rough eye; Wv, extra wing
veins; W.su, weak suppressor; W.en, weak enhancer; --, no effect; ND, not
done; Sup, suppressor; Enh, enhancer; SemLth, semi lethal. vg-//hid refers
to vg-Gal4;UAS-hid.
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were roughly mapped by meiotic recombination. Complementation analysis
using phenotype and map information placed 133 of the modifiers into 13
complementation groups. The remaining mutants represented single hits or
had no recessive phenotype and could not be placed into a complementation
group. The location and phenotype of some of these, however, suggest that
they may be viable alleles of identified lethal complementation groups.
To enrich for mutants that specifically affect rpr and hid induced cell
death, rather than expression from the GMR promoter or general eye
development, modifiers were subjected to a panel of secondary screens
(Tables 1 and 2). The effect of modifiers against GMR-phyl or GMR-rho
induced eye phenotypes, which are unrelated to cell death, were assessed. It
was surmised that death specific mutants would not affect these phenotypes
whereas those affecting GMR promoter expression or eye development
would (Chang et al., 1995; Hariharan et al., 1995). Conversely, mutants
involving apoptosis genes were expected to modify cell death phenotypes in
alternative contexts, while those affecting GMR promoter expression or eye
development, whose effects should be eye specific, would not. To this end,
dominant suppressors from the GMR-hid screen were tested for their ability
to suppress the lethality induced by hs-hid or the ablated wing phenotype
resulting from vg-Gal4, UAS-hid expression.
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Finally, to compare the

similarity of rpr, hid and grim induced cell death pathways, modifiers were
tested against GMR-rpr, GMR-hid and GMR-grim phenotypes.

These

secondary screens allowed for the elimination of several complementation
groups including glass, which encodes the transcription factor that drives
GMR expression, Su(GMR)2A and Su(GMR)3A, which are known to
indirectly and non-specifically affect GMR promoter expression, and
Su(GMR-hid)3A and Su(GMR-hid)3B, which have not been assigned to
previously characterized genes (Barrett et al., 1997; Moses and Rubin,
1991).

Also eliminated were 4 alleles linked to the parental GMR-rpr

transgene. The remaining mutants comprised a cell death enriched subset of
modifiers consisting of 40 mutants that fall into 6 complementation groups,
plus 18 single alleles.
Of the 6 complementation groups identified in these screens, 3
corresponded to genes that regulate EGF receptor (EGFR) signaling. Five
loss-of-function (lof) alleles each of gap1 and sprouty, both negative
regulators of EGFR/MAPK signaling, were recovered as strong, hid specific
suppressors. These mutants have been further characterized and were used
to demonstrate that EGFR/MAPK signaling specifically inhibits the
proapoptotic activity of Hid by direct phosphorylation and to provide a
mechanistic link between survival signaling and the apoptotic machinery
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(Bergmann et al., 1998). Five lof Star alleles were isolated as enhancers of
GMR-rpr. Star is required for the correct processing of Spitz, a stimulatory
ligand of EGFR (Shilo, 2005). Though EGFR/MAPK signaling does not
directly impinge on Rpr activity, star lof alleles exhibit a dominant rough
eye phenotype, perhaps in part due to a reduced suppression of endogenous
Hid activity and consequently appear as enhancers of GMR-rpr.
Anticipated was the recovery of mutations in diap1, a known
regulator of hid and rpr induced cell death and accordingly, 10 diap1 alleles
were isolated in these screens. Mutations in diap1 included both loss-offunction (lof) alleles that enhance rpr, hid and grim induced death and two
classes of gain-of-function (gof) alleles that either potently suppress death
induced by all three RHG proteins or, alternatively, potently suppress hid
induced death but enhance rpr and grim induced death. This latter class of
gof mutants represents RING domain mutations in diap1 and highlights a
significant distinction between the hid pathway and the rpr and grim
pathways. The diap1 mutants isolated in these screens have been pivotal in
several structure-function analyses employed to construct our current models
of apoptosis and are described extensively elsewhere (Goyal et al., 2000;
Ryoo et al., 2002; Wilson et al., 2002).

71

The two remaining complementation groups originally defined
previously uncharacterized genes and Su(GMR-hid)2A remains as such. The
other group, consisting of 12 alleles, was of particular interest because these
mutants display a differential modulation of the hid, rpr and grim pathways
in a manner reminiscent of diap1 RING mutants, enhancing GMR-rpr and
GRM-grim phenotypes but having no effect on or suppressing those of
GMR-hid.

These alleles were mapped using a combination of meiotic

recombination, P-element induced male recombination and deficiency
mapping to a 74 Kb interval on the right arm of the third chromosome. Two
converging chromosome walks were then conducted to identify and clone
dbruce. This enormous 4852 amino acid protein, containing an N-terminal
BIR and C-terminal UBC domain, is the Drosophila ortholog of mouse
Bruce and human Apollon (Hauser et al., 1998; Vernooy et al., 2002). The
unique combination of a BIR domain and a UBC domain immediately
suggested a model in which dBruce inhibits apoptosis by ubiquitinating, via
its UBC domain, proapoptotic BIR binding factors such as caspases, Rpr or
Grim. Evidence that dBruce is cytoprotective against caspases and partial
characterization of some of the dbruce mutants isolated in these screens has
been described (Arama et al., 2003). Molecular lesions in 9 of the dbruce
alleles have been identified.
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Of the remaining 18 modifiers that could not be placed into
complementation groups, 1 was identified as an allele of delta and 5 others
(9-4e, 9-5e, 14-1e, 14-2e and 16-3e) possibly represent weak hypomorphs of
diap1 as they have similar differential phenotypes and map close to the
diap1 locus.
The Su(21-3s) mutant was the only remaining uncharacterized allele
found to potently and dominantly suppress all the hid-induced phenotypes
tested (wing/eye/organismal lethality) without affecting GMR-phyl (Table
2). It was also reported in the screen to dominantly suppress GMR-rpr and
GMR-grim induced eye phenotypes. The dominant suppressor phenotype
associated with Su(21-3s) was roughly mapped by meiotic recombination to
the right arm of the 3rd chromosome near the visible marker, curled. This is
the same general area to which dbruce was roughly mapped. However,
unlike dbruce homozygotes, which are male sterile, Su(21-3s) homozygotes
were reported to be fertile with no obvious phenotype. In addition, all 12
dbruce alleles were found to enhance GMR-rpr and GMR-grim induced
phenotypes and not to affect those of GMR-hid (excepting the lethal allele
dbruce23-6s). Since no cell death genes that could readily be mutated to
explain the Su(21-3s) suppressor phenotypes were immediately obvious in
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the area, the possibility that Su(21-3s) represented a mutation in a novel
apoptotic regulatory element was considered.
Despite the differences in Su(21-3s) and dbruce phenotypes, it was
also considered that Su(21-3s) might be an unusual allele of dbruce given
their mutual proximity. Therefore, Su(21-3s) was included in the analysis
that led to the cloning of dbruce. Southern blot analysis of the interval to
which dbruce had been mapped unexpectedly revealed a polymorphism in
Su(21-3s) relative to wildtype. Further localization of this polymorphism by
PCR uncovered a 2Kb insertion within a presumptive intron of the unknown
gene CG11870.

This previously uncharacterized locus is predicted to

encode a protein Ser/Thr kinase (Fig. 2). Interestingly, this kinase was also
reported to contain a putative caspase recruitment domain (CARD), which is
found in a number of known cell death regulators. Taken together, these
data suggested that the phenotypes associated with Su(21-3s) might derive
from a mutation in CG11870 and the possible presence of a CARD domain
was sufficiently intriguing to warrant further study of this gene.

Recharacterization of Su(21-3s) phenotypes
Since a considerable amount of time had lapsed between the original
characterization of mutants isolated in the genetic screens conducted by
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Fig. 2.2. Schematic diagram illustrating the predicted gene structure of
CG11870. For simplicity, only two of four mRNAs are depicted in blue.
Both are supported by EST data from adult testes (AT) and third instar larva
(LP) and both are expected to encode a protein of 1427 amino acids. Along
with a high probability Ser/Thr kinase domain, several other motifs are
predicted with a lower probability, including a CARD domain within the
kinase motif. The red triangle indicates the location of the strider transposon
insertion in Su(21-3s) flies and the red arrow indicates the binding site of the
DIG-labelled probe used for northern analysis.
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Agapite et al. and initiation of the studies reported here, we first sought to
recharacterize in greater detail the phenotypes associated with the Su(21-3s)
mutant.

This analysis led to a number of unanticipated findings that

confounded somewhat are initial hypothesis concerning this mutant. As can
be seen from the data in Table 2, Su(21-3s) had been classified as recessive
viable with no obvious phenotypes. Specifically, Su(21-3s) was stated to be
recessive fertile (Agapite, 2002). In our follow up examination, however, it
was discovered that Su(21-3s) in fact harbored a mutation that rendered it
recessive male and female sterile. Dissection of gonads from adult Su(213s) flies revealed severely atrophied testes and ovaries in heterozygotes and
an even more marked degeneration of testes from male homozygotes.
Ovaries in homozygous Su(21-3s) females could not be isolated, presumably
because they were too deteriorated (Fig. 3). The reason for the discrepancy
between our observations here and those first reported remains unclear. It is
possible, given the nature of mutagenesis in general and the mosaicism
associated with chemical mutagens in particular, that a second mutation in
the background of Su(21-3s) flies initially went undetected and over time
was fixed in the population (Rubin, 1990). Alternatively, a spontaneous
mutation may have arisen at some point. Why in either case a recessive
sterile mutation in a mixed population would persist is another matter for
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speculation. Perhaps it conferred some sort of survival advantage in the
context of other mutations located on the mutagenized chromosome. It also
had to be considered that slight imprecisions can occur during the execution
of such large scale screens involving a number of different individuals. In
any event, no determination could immediately be made as to whether the
sterility and suppressor phenotypes of Su(21-3s) were linked given that
mutations with both features are known (Baum et al., 2007; Mendes et al.,
2006). It was therefore resolved to map both phenotypes in order to clarify
their relationship with each other and to the polymorphism identified in
CG11870.
In addition to uncovering the sterility phenotype associated with
Su(21-3s), our reanalysis of its suppressor phenotype exposed another
discrepancy with the data originally reported in the screens. Briefly, Su(213s) was originally reported to suppress GMR-hid, GMR-rpr and GMR-grim
induced eye phenotypes.

A careful reevaluation of these interactions

however, clearly demonstrated that Su(21-3s) specifically suppresses only
hid induced phenotypes and has no affect on GMR-rpr or GMR-grim. The
details and consequences of this finding are presented in the next chapter
and will not be discussed further here.
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Fig. 2.3. The Su(21-3s) mutation results in atrophy of the testes in males (B
and C) and the ovaries in females (E). Ovaries could not be found in Su(213s) homozygous females. Yw testes (A) and ovaries (D) are included for
comparison. All images were taken at the same magnification.
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Despite a partial reclassification of Su(21-3s) phenotypes, the
evidence implicating CG11870 as a gene of interest remained unchanged.
Accordingly, while the genomic mapping of Su(21-3s) phenotypes was
underway, we preceded with a preliminary characterization of CG11870.

CG11870 is predicted to encode a protein Ser/Thr kinase
The Flybase annotation for CG11870 reports a gene length of 35581
bp with a cytological map location 86A3-86A6. Strong EST data derived
from most tissues and stages indicate the production of four differentially
spliced mRNAs ranging in size from 4357 bp to 5076 bp. The shortest
mRNA consists of 12 exons, lacks coding exon 6 and is expected to encode
a protein of 1180 aa. The remaining mRNAs all contain 13 exons including
coding exon 6 and are predicted to encode a protein of 1427 aa. Both
protein isoforms are electronically inferred to function as receptor signaling
Ser/Thr protein kinases in cytoskeleton organization and biogenesis. At the
time these studies were initiated, CG11870 was also predicted to comprise a
putative CARD, albeit with low probability, as well as a number of other
interesting features (Fig. 2).

Interestingly, the short protein isoform of

CG11870 alone includes a so called TREACLE or TCS fingerprint,
implicated in nucleolar trafficking (Wise et al., 1997). The only proteins
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with significant homology to CG11870 outside of the universally conserved
kinase domain and the other recognized conserved motifs come from Aedes
aegypti and Anopheles gambiae. Other than these electronically inferred
insights, CG11870 remains largely uncharacterized.

Northern analysis of CG11870 mRNA
Su(21-3s) mutants were determined by PCR to contain an insert of
approximately 2Kb within intron 3 of the CG11870 locus.

Subsequent

analysis by sequencing revealed this insertion to be a 1828bp degenerate
fragment of the Strider or Juan non-LTR retrotransposon. To date, 9 of
these elements have been detected in the Drosohophila genome, 6 of which
are full length (Kaminker et al., 2002).

Non-LTR retrotransposons are

eukaryotic mobile genetic elements that transpose by reverse transcription of
an RNA intermediate and can be mobilized during mutagenesis experiments.
It was unclear whether the insertion identified in Su(21-3s) would disrupt
proper splicing or expression of CG11870 and whether this was the cause of
the dominant suppressor phenotypes observed in this mutant. We therefore
performed a northern analysis of wildtype and Su(21-3s) mutant flies using a
DIG-labeled probe directed against the last coding exon of CG11870. A
faint but clearly visible band of about 5kb was detected in total RNA
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prepared from adult wildtype and mutant flies and from wildtype embryos
(Fig 4). Quantitation of the blot using actin mRNA as a loading control
revealed no significant difference in expression level between wild type and
mutant flies and no differences in transcript size were detected. This 2Kb
insertion does not appear to affect CG11870 expression in the adult fly and
argued against an involvement of CG11870 in Su(21-3s) phenotypes.
However, the possibility remains that the insertion might have tissue or
timing specific effects on expression or result in minor splicing defects not
detectable by northern.

Overexpression of CG11870 in the fly eye suppresses GMR-hid
Though an attractive feature of dominant modifier screens is the
ability to detect and therefore isolate weak hypermorphs, in general it is
much easier to induce a loss-of-function mutation in a gene than a gain-offunction mutation, We presumed this to be the case for Su(21-3s) and
assumed that, if a hypomorphic allele of CG11870 suppresses cell death,
then a hypermorph may induce it. To test this, we overexpressed a cDNA
encoding the long isoform of CG11870 in the fly eye using the GMR
promoter. A total of 15 individual GMR-CG11870 transgenic lines were
generated and examined. No observable phenotypes were detected in any of
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Fig. 2.4. Northern analysis of total RNA from adult flies with a Dig-labeled
RNA probe made from the 3’ exon of CG11870. The probe detects a faint
band at the correct size of ~5 Kb confirming that CG11870 is an expressed
gene.

Quantitation of the blot using actin mRNA as a loading control

revealed no significant differences in expression between wildtype controls
(yw and Sb/TM6B) and Su(21-3s). Molecular weight markers are indicated
on the left.
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the lines when either one or two copies of the transgene were present. This
suggests that CG11870 is not a pro-apoptotic molecule.

When these

transgenic lines were placed in a GMR-hid background however, several
lines over-expressing CG11870 were found to weakly suppress the GMR-hid
induced rough eye phenotype (Fig. 5). A similar effect was observed when
we used GMR-Gal4 in conjunction with UAS-CG11870 to drive expression
in the eye. As with GMR-CG11870, GMR-Gal4/UAS-CG11870 exhibits no
observable phenotypes on its in own, but is able to suppress the rough eye
phenotype induced with GMR-hid (Fig. 6). Taken together, these overexpression studies raise the intriguing possibility that CG11870 can inhibit
hid induced cell death. In this case, the insertion present in Su(21-3s) flies
would have to be a gain-of-function mutation. This seemed unlikely given
the Northern results and for additional reasons discussed below. Instead, it
seems we may have uncovered this feature of CG11870 strictly by
serendipity.

The Su(21-3s) sterility phenotype maps to the zpg locus
Given that the sterility phenotype of Su(21-3s) was recessive, we
assumed it to be loss of function and hence amenable to deficiency mapping.
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Fig. 2.5. Flies overexpressing the long isoform of CG11870 can suppress
the GMR-hid induced rough eye phenotype. The genotype of each eye is
indicated immediately underneath. B3, B4, B13, B38 and B53 represent
independent

GMR-CG11870

transgenes.

Transheterozygous

combinations were used to minimize transgene insertion affects.
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allelic

To this end, we obtained 22 overlapping molecularly defined deletions from
the Exelixis stock center covering the interval to which the Su(21-3s)
suppressor phenotype had originally been roughly mapped in the modifier
screens. This region, from 84B2 to 88C1 of the right arm of the third
chromosome, also includes the CG11870 locus as well as dbruce. All 22 of
these deletions complemented the sterility phenotype of Su(21-3s). This
strongly indicated that the sterility of Su(21-3s) flies was neither due to a
mutation in dbruce nor related to the polymorphism identified in CG11870.
Furthermore, these results demonstrated that the sterility phenotype of
Su(21-3s) did not map to this region and therefore was not linked to the
suppressor phenotype.

This established that Su(21-3s) contained two

separable mutations, one recessive that causes male and female sterility and
the other a dominant suppressor of hid induced phenotypes.
To further localize the gene responsible for the sterility phenotype, we
first thought to continue with the deficiency mapping.

However, while

waiting for the arrival of a new batch of deletions, it was noticed that the
atrophied gonads of Su(21-3s) resembled somewhat those of mutants under
analysis in an unrelated study. This other investigation was focused on the
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Fig. 2.6.

Overexpression of CG11870 in the eye using the Gal4/UAS

system also suppresses GMR-hid induced apoptosis. Two examples are
given for each genotype, which is indicated immediately underneath each
pair of eyes.

E11, E19 and E69 represent independent UAS-CG11870

transgene insertions.
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involvement of caspases during Drosophila spermatogenesis and a collection
of male sterile mutants with defects in spermatid individualization had been
obtained from the Zuker stock of mutagenized flies. The third chromosome
collection of this publicly available stock consists of 6,000 partially
characterized lines derived from an EMS mutagenesis (Koundakjian et al.,
2004). Remarkably, of these 6000 mutants, only 24 are reported to be both
male and female sterile, suggesting that relatively few genes can be mutated
to elicit the sterility of both sexes in Drosophila. When these 24 lines were
crossed to Su(21-3s), five failed to complement its sterility phenotype. A
search of the literature fortuitously uncovered two of these Zuker mutants
that had previously been identified as loss of function alleles of zero
population growth (zpg) (Tazuke et al., 2002). The zpg locus in the Su(213s) mutant was subsequently sequenced and a mutation at position 662 of
the cDNA resulting in an amino acid substitution (G221D) within a highly
conserved region of the protein was identified. This confirmed that the
sterility phenotype of Su(21-3s) was due to a loss of function mutation in
zpg and that the two Su(21-3s) phenotypes were not linked. Zpg maps to
65B5 on the left arm of the third chromosome and the two Su(21-3s)
phenotypes were easily separated by meiotic recombination. All subsequent
analyses of the Su(21-3s) mutant, now recessive fertile as initially reported,
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were conducted in this fresh genetic background and are discussed at length
in the following chapter.

Discussion
In this chapter, we describe the initial isolation and characterization of
the Drosophila mutant Su(21-3s). We also present preliminary molecular
data on the predicted protein Ser/Thr kinase CG11870 and provide evidence
showing that a mutation in this gene is unlikely to give rise to the Su(21-3s)
mutant phenotypes as originally hypothesized.
The dominant hid suppressor, Su(21-3s), is the product of a genetic
screen carried out to isolate genes that can modulate the eye ablation
phenotypes elicited by expressing hid or rpr under the control of an eyespecific promoter. Roughly 500,000 flies were screened and 167 dominant
modifiers recovered. Secondary screens allowed us to compile a cell death
specific subset of 58 modifiers of which 40 could be placed into six
complementation groups that define both known and unknown genes. This
includes 3 genes, Star, gap and sprouty involved in EGFR/MAPK signaling,
the known cell death regulator diap1, the enormous BIR and UBC
containing protein dbruce and a gene, Su(GMRhid)2A, that remains to be
identified.

Analysis of these mutants have provided several valuable
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insights concerning the regulation of apoptosis and generated a multitude of
tools that have proven essential in a number of studies. For example, the
large number of diap1 mutants obtained in this study, both gain and loss of
function, permitted structure function assessments of Diap1 that provided
strong in vivo evidence for mechanistic models of IAP apoptosis inhibition
(Goyal et al., 2000; Wang et al., 1999; Zachariou et al., 2003). Moreover,
diap1 RING mutants derived from this screen have been used to implicate
the ubiquitin system in apoptosis regulation and to provide evidence that
degradation of caspases as well as Diap1 itself are key regulatory events in
cell survival and death (Ryoo et al., 2002; Wilson et al., 2002).
Su(21-3s), included in the cell death specific subset of modifiers
described above, was isolated as a strong dominant suppressor of GMR-hid.
This mutant was reported at the time the screen was originally conducted to
be viable with no obvious recessive phenotypes, to dominantly suppress hid
induced organismal lethality and wing phenotypes and to map near the
marker curled on the right arm of the third chromosome.

It was also

reported to be a suppressor of GMR-rpr and GMR-grim. Finally, because
the complementation group encompassing dbruce alleles mapped to a
similar position on the third chromosome, Su(21-3s) was included in the
molecular analysis that led to the identification and cloning of dbruce.
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During the course of this analysis, a 2Kb insertion within the unknown gene
CG11870, was identified in Su(21-3s) flies. This suggested the possibility
that a mutation in CG11870 could be responsible for the phenotypes
associated with Su(21-3s). Our suspicions were bolstered by the fact that
CG11870 was predicted to encode a protein Ser/Thr kinase with a putative
CARD, a motif present in several known cell death regulators (Park et al.,
2007).
Though the features of Su(21-3s) were considered interesting enough
to warrant further study, it was a number of years until the investigation
reported here was initiated. When the Su(21-3s) mutant was next examined,
it was discovered to harbor a recessive sterility contrary to its initial
characterization.

We first showed using deletions that this sterility

phenotype was not related to CG11870 or dbruce and that it was separable
from the suppressor phenotypes associated with Su(21-3s).

Subsequent

analysis revealed that the sterility phenotype was due to a mutation in zpg, a
germline-specific gap junction required for the survival of early
differentiating germ cells (Tazuke et al., 2002). Fearing this mutation might
confound analysis of the suppressor phenotype, it was crossed out of the
Su(21-3s) line by meiotic recombination. This yielded a Su(21-3s) line that
is fully fertile. Though the detection and removal of this zpg mutation was
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unexpected, it was not relevant to our supposition that the insertion in
CG11870 might be responsible for suppressor phenotypes that remain
associated with Su(21-3s).

We therefore preceded with a preliminary

characterization of this predicted kinase.
Since the insertion found in CG11870 of Su(21-3s) falls within an
intron, it could only be mutagenic by disrupting expression in some way.
Northern analysis of CG11870 transcripts from adult flies detected a faint
RNA band of the correct size (~5Kb), but failed to reveal any alterations in
size or levels between wildtype and Su(21-3s). This result argues that the
insertion present in Su(21-3s) does not affect the transcription of CG11870
and that it can not account for the phenotypes observed in Su(21-3s) flies. In
addition, the entire CG11870 ORF in wildtype and Su(21-3s) flies was
sequenced but also revealed no differences, precluding the possibility that a
mutation in the coding sequence of CG11870 was concomitantly induced by
a transposition event.
When CG11870 was over-expressed in the fly eye, no cell death was
observed.

Instead, overexpression of CG11870 was able to moderately

suppress the cell death induced by GMR-hid. Though interesting in its own
right, this result in fact argues that CG11870 is not related to the suppressor
phenotype of Su(21-3s). For this to be the case, two improbable scenarios
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would have to be invoked. First, the insertion in Su(21-3s) flies, which falls
within an internal intron of CG11870, not upstream or within the first intron
(Fig. 2), would have to be a strong gain-of-function mutation that
significantly increases CG11870 expression to a level comparable to that
achieved by GMR transgenes. Second, given the results of the northern
analysis, this considerable increase in expression would have to be restricted
to a pre-adult stage. Finally, Su(21-3s) is a potent endogenous suppressor of
GMR-hid, whereas strong transgenic overexpression of CG11870 gives only
a moderate suppression. Taken together, these data compellingly indicate
that the insertion identified in Su(21-3s) flies does not give rise to the
observed suppressor phenotypes and that another gene is responsible. As is
described in the next chapter, this indeed turned out to be the case.

Experimental Procedures
Fly stocks and genetics
The following fly stocks were used for the dominant modifier screens:
GMR-rpr81 (White et al., 1996), GMR-rpr34 Cyo/Sco (Bergmann et al.,
1998), GMR-hid10 and hs-hid3 (Grether et al., 1995), GMR-grim (Chen et al.,
1996), GMR-phyl (Chang et al., 1995), GMR-rho1 (Hariharan et al., 1995),
vg-Gal4 (F.M. Hoffmann, unpublished), UAS-hid (Zhou et al., 1997).

92

Stocks for meiotic recombination mapping (ru1 h1 th1 st1 cu1 sr1 es ca1 and
ru1 h1 th1 st1 cu1 sr1 es Pr1 ca1/TM6B, Bri1, Tb1) and GMR-Gal4 were
obtained from the Bloomington Stock Center (Bloomington, IN).

Flies

carrying GMR-CG11870 and UAS-CG11870 were generated by P elementmediated transformation according to standard protocols. All other lines
were generated by meiotic recombination of the appropriate alleles.
Dominant modifier and reversion screens were performed as
described in Fig. 1 (Agapite, 2002).

Modifiers were mapped to a

chromosome, balanced and their recessive phenotypes determined.
Complementation analysis was performed on mutants of the same
chromosome exhibiting similar recessive phenotypes. Dominant modifiers
on the third chromosome were mapped by meiotic recombination using the
rucuca mapping chromosome. Male sterility was assessed by mating twenty
homozygous mutant males individually to Canton-S females. The mutants
were considered to display some degree of sterility if fewer than 20% of the
crosses gave rise to at least forty progeny.
All crosses and suppression experiments were carried out at 25°C
except crosses with vg-Gal4 and UAS-hid, which were performed at both
18°C and 25°C. Suppression experiments with hshid were done by heat
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shocking 1st instar larvae at 37°C for 15 minutes. Flies were raised on
standard cornmeal-molasses medium at 25°C unless otherwise indicated.
For analysis of gonads, the testes and ovaries of 3-5 day old adult flies
were dissected into PBS and immediately visualized. Fertility tests were
performed by placing ten young adult males with five wild-type virgin
females in a vial at 25°C, and vials were scored for offspring after ten days.
Flies were raised on standard cornmeal-molasses medium.

Identification of a polymorphism in the Su(21-3s) mutant
The 2Kb polymorphism in Su(21-3s) flies was identified as previously
described (Agapite, 2002).

Briefly, the dominant suppressor phenotype

associated with Su(21-3s) was roughly mapped by meiotic recombination to
the right arm of the 3rd chromosome near the visible marker, curled. Dbruce
mapped to a 74Kb interval in this general area and for this reason Su(21-3s)
was included in the analysis that led to the cloning of dbruce. Genomic
Southern was used to screen this interval using individual EcoR1 fragments
as probes. One fragment revealed a polymorphism in Su(21-3s) relative to
wild-type and was partially sequenced. PCR using primer pairs designed to
give 1 Kb products that spanned this fragment was performed with both
wildtype and Su(21-3s) genomic DNA and one primer pair yielded a 1Kb
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product from wildtype and a 3Kb product from Su(21-3s) templates. These
products were sequenced and revealed that Su(21-3s) contained an insertion
in the third intron of the predicted gene CG11870.

Molecular Biology
A full length cDNA clone encoding the long isoform of CG11870 was
obtained from the Drosophila Genomics Resource Center (clone ID:
GM10858) and the entire ORF was subcloned into the pUAST (Brand and
Perrimon, 1993), pGMR (Hay et al., 1994) and pSPT18 (Roche) vectors to
generate

pUAST-CG11870,

pGMR-CG11870

and

pSPT18-CG11870,

respectively. Plasmid DNA for each construct was isolated using the Qiagen
Plasmid Maxi Prep kit (Qiagen).
For Northern analysis total RNA was extracted from 100 adult yw and
Su(21-3s) flies using the TRIZOL reagent according to the manufacturer's
instructions (Invitrogen). Northern analysis was performed by using 1ug of
total RNA per sample and blotting with a DIG-labeled RNA probe
complimentary to the last 300bp of CG11870 coding sequence according to
the Dig-Northern Starter Kit (Roche). Probes were prepared with 1ug of
linearized pSPT18-CG11870 DNA and SP6 RNA polymerase using the DIG
RNA Labeling Kit (Roche).
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CHAPTER 3.
Molecular and Biochemical Analysis of ras1R68Q, a Viable Gain of
Function Mutation in the Switch II Region of Drosophila ras1.
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Summary
Cells are continuously exposed to a multitude of environmental cues and are
required to integrate the resulting signals into cell fate decisions, including
whether to live or die. Among the many signaling pathways that control
these fate decision, mitogen-activated protein kinase (MAPK) family
members are crucial for the transduction of signals that mediate survival,
proliferation and differentiation. This evolutionarily conserved pathway can
respond to a number of extracellular inputs, such as growth factors, to
promote cell survival by inhibiting the activation of apoptosis. A central
regulator of these signal transduction processes is the small GTPase Ras,
which is involved in virtually every aspect of cell biology. The critical
nature of Ras in physiologic homeostasis is underscored by the fact ~20% of
all human tumours contain an activating mutation in one the Ras genes.
Much of our understanding of the role Ras proteins play in development has
come from studies in genetic systems such as the developing Drosophila eye
C. elegans vulva. Here we report the identification and characterization of a
novel gain-of-function mutation in the switch II region of RAS85D (ras1),
the Drosophila homologue of mammalian N-ras, K-ras and H-ras. Though
several loss of function alleles have been described for drosophila ras1, this
mutation represents the first endogenous ras1 hypermorph to be isolated.
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Introduction
The development of multicellular organisms requires the tight
coordination of cell proliferation, cell differentiation and cell death in order
to correctly specify cell fate and number. One model that describes how this
can be achieved is the trophic theory of survival. Originally postulated to
explain the massive neuronal cell loss during development of the vertebrate
CNS, the trophic theory presumes that in the absence of extracellular
survival factors, cells die by the engagement of a default cell death program.
Cells compete for these trophic factors, secreted from neighboring cells in a
limited amount, thereby ensuring that only an appropriate number survive
(Raff, 1992). This ‘social control’ of cell survival ensures the integrity of
tissues by matching the correct number of different cell types to each other.
The MAPK pathway is one of many conserved signaling modules that
respond to extracellular cues and relay survival signals to the cell interior.
The signaling relay consists of a transmembrane receptor that binds to
extracellular factors, intracellular proteins that engage activated receptors
and amplify the signal and effector molecules that transduce the signal to
cytoplasmic and nuclear targets.

Signals are propagated via a protein

phosphorylation cascade by a series of protein kinases which act
downstream of the small GTPase Ras (Seger and Krebs, 1995).
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Ras proteins are guanine nucleotide binding proteins that act as
molecular switches to integrate the signal transduction pathways involved in
several aspects of normal cell growth and malignant transformation
(Colicelli, 2004). The remarkable fact that ~20% of all human tumours have
undergone an activating point mutation in one of the Ras genes emphasizes
the necessity of understanding in detail the mechanistic workings of this
signal transducer and the biological contexts in which it operates (Bos,
1989). Oncogenic mutations in Ras occur most frequently at codons 12,13
or 61 and result in an enzyme with a deficient GTPase activity that is
refractory to stimulation by GTPase Activating Protein (GAP) (Scheffzek et
al., 1997). Ras thus remains trapped in an active state because Ras is ‘on’
when bound to GTP and is switched ‘off’ by hydrolyzing bound GTP to
GDP. Inhibition of Ras GTPase activity therefore stabilizes Ras in its active
conformation, prolonging its recruitment and activation of downstream
signaling components.
Much of our understanding of Ras-mediated signaling is derived from
a combination of biochemical experiments conducted in mammalian tissue
culture and screens conducted in the workhorses of developmental genetics,
Drosophila melanogaster and Caenorhabditis elegans (McCormick, 1994).
For example, the power of Drosophila genetics proved instrumental in
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defining how Ras-mediated signaling regulates the specification and
differentiation of R7 photoreceptors in the fly eye (Gaul et al., 1992; Rebay
et al., 2000; Simon et al., 1991). Furthermore, findings from the genetic
screens described in the previous chapter and from those conducted by
others, have defined a mechanism by which Ras-mediated signaling can
directly inactivate a critical component of the intrinsic cell death pathway
(Bergmann et al., 1998; Downward, 1998; Kurada and White, 1998). Such
successes have helped to garner credibility and visibility for Drosophila as a
model organism in cancer research (Vidal and Cagan, 2006).
In Drosophila, ras85D (ras1) is the ortholog of mammalian H-ras, Kras and N-ras (Neuman-Silberberg et al., 1984).

As a complimentary

approach to the use of genetic screens, Ras has also been extensively studied
in Drosophila by targeted overexpression of activated Ras alleles in a variety
of tissues and paradigms.

For example, ras1V12 has been expressed in

imaginal discs and larval hemocytes to examine cell proliferation,
differentiation and cell death (Asha et al., 2003; Fortini et al., 1992; Karim
and Rubin, 1998). The use of such transgenic approaches in Drosophila has
helped to elucidate the role of Ras in a variety of signaling pathways and
developmental contexts.
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In the previous chapter, we described the isolation and preliminary
phenotypic characterization of the Drosophila mutant Su(21-3s).

This

mutant was identified as a dominant suppressor of GMR-hid induced cell
death in a genetic modifier screen.

Here we report on the further

characterization of Su(21-3s) and show that its associated suppressor
phenotypes derive from a hypermorphic mutation of ras1.

Though

numerous loss of function alleles have been described for ras1, the mutation
described here represents the first endogenous gain of function allele to be
identified. The phenotypic consequences of this hypermorph in various
developmental contexts is investigated.

Results
Phenotypic characterization of Su(21-3s)
As stated in the previous chapter, we sought to re-examine more
rigorously the suppression phenotypes of Su(21-3s) in the eye by testing the
modifier effects of one or two copies of Su(21-3s) against various GMR
expression constructs (Fig. 1). This analysis confirmed unequivocally that
Su(21-3s) potently suppresses GMR-hid induced cell death in a dosage
dependent manner (Fig. 1A,B).

Unexpectedly, however, we found the

suppression of GMR-rpr and GMR-grim phenotypes, though detectable as
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Fig. 3.1. GMR-hid but not GMR-grim or GMR-rpr induced cell death is
dominantly suppressed by Su(21-3s) in a manner that requires intact MAPK
phosphorylation sites in hid.

(A-F) GMR driven expression of IAP-

antagonist induces cell death in the eye. Cell death is strongly suppressed by
one (′) or two (′′) copies of the Su(21-3s) chromosome when induced by
either a weak allele, GMR-hid1M (A) or strong allele, GMR-hid10 (B) of hid,
but is very weakly suppressed by Su(21-3s) when induced GMR-grim (E) or
GMR-rpr (F). In addition, Su(21-3s) suppresses cell death induced by a hid
allele lacking 3 of 5 predicted MAPK phosphorylation sites, GMR-hidAla3 (C)
but not by GMR-hidAla5 (D), a hid allele lacking all 5 MAPK consensus. sites
(Bergmann et al., 1998).

(G-H) Death of larval hemocytes induced by

expression of hid under control of the hemocyte specific driver Hml is also
partially suppressed by the Su(21-3s) mutation.

(G) EGFP is used to

visualize hemocytes in wildtype 3rd instar larva: Hml-GAL4, 2xUAS-EGFP.
(H) Overexpression of Hid in hemocytes results in their complete ablation
by the 1st instar larval stage: Hml-Gal4, 2xUAS-EGFP; UAS-hid. (I) Su(213s) is able to partially suppress hemocyte death induced by HID. Surviving
hemocytes appear to be concentrated within the lymph glands: Hml-Gal4,
2xUAS-EGFP; UAS-hid, Su(21-3s). Genotypes are as indicated except 213s refers to Su(21-3s).
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initially reported in the screen, to be extremely weak, even in the presence of
two copies of Su(21-3s) (Fig. 1E,F). Given that hid is highly expressed in
the developing eye, we believe the small effect exerted by Su(21-3s) on
GMR-rpr and GMR-grim is due to a suppression of endogenous Hid activity
and not on Rpr or Grim (Grether et al., 1995). We therefore conclude that
Su(21-3s) is a hid specific suppressor that again illustrates a distinction
between the hid, grim and rpr pathways.
It has been demonstrated that Hid activity is regulated by the
EGFR/MAPK pathway in a manner that depends on intact MAPK
phosphorylation sites in Hid. Intriguingly, our analysis here reveals that
Su(21-3s) readily suppresses GMR-hidAla3, a hid allele lacking 3 of 5
predicted MAPK phosphorylation sites, but fails to suppress GMR-hidAla5,
which is missing all 5 MAPK sites (Fig. 1C,D) (Bergmann et al., 1998).
This requirement for one or two of the predicted MAPK phosphorylation
sites in Hid (Ser-121 and Thr-228) suggested that Su(21-3s) might be
mediating its suppressive effects through the EGFR/MAPK pathway.
We further extended analysis of the Su(21-3s) suppression phenotype
to the developmental context of larval hemocytes, an important model
system for the study of vertebrate haematopoiesis (Jung et al., 2005; Wood
and Jacinto, 2007). Drosophila hemocytes require trophic signaling from
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multiple pathways for their survival and in its absence undergo caspase
dependent cell death (Bruckner et al., 2004; Matova and Anderson, 2006).
Using a hemocyte specific promoter to drive expression of EGFP, we
visualized hemocytes in wandering 3rd instar larva (Fig. 1G) (Goto et al.,
2003). Ectopically expressing Hid using the same driver results in complete
ablation of hemocytes by the 1st instar larval stage (Fig. 1H). Su(21-3s) is
able to partially suppress this cell death such that anterior hemocyte
aggregates become readily visible, possibly due to “cannibalistic
phagocytosis” by surviving hemocytes as described by Bruckner et al (Fig.
1I).

Su(21-3s) is a gain-of-function allele of ras85D (ras1)
In order to identify the gene responsible for the Su(21-3s) phenotype,
we mapped it by a second, finer round of meiotic recombination to a 1 Mb
interval between 85A and 85E, then further localized the mutation by Pelement mediated male recombination to a 270 Kb interval between 85D11
and 85E1 (Fig. 2A). Given that Su(21-3s) differentially suppresses hid, but
not grim or rpr in a manner reminiscent of EGFR/MAPK mutants, we
suspected that Su(21-3s) might be a hypermorphic allele of ras85D(ras1),
which is located within this interval. Therefore, we sequenced ras1 in a
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Fig. 3.2.

Su(21-3s) is a gain of function allele of ras85D(ras1), the

Drosophila ortholog of human N-ras, H-ras and K-ras. (A) The cell death
suppression phenotype of Su(21-3s) mutants was mapped by meiotic
recombination to the region of the 3rd chromosome indicated by the large
horizontal arrow. This interval was further narrowed by P-element induced
male recombination mapping to the region indicated by the short arrow.
This shorter interval corresponds to 5.162-5.452 Mb on the physical map
and an enlargement of this interval is shown below indicating the ORFs
contained therein, including ras85D or ras1, outlined with a red box. The
ras85D locus was subsequently sequenced in a candidate gene approach and
a G to A transition in exon3 was identified. This transition results in an
amino acid substitution at position 68 of the ras1 protein (Ras1R68Q.) (B)
Amino acid alignment of the universally conserved Switch II region of Ras.
The Su(21-3s) mutation is highlighted in yellow. (C) Schematic diagram of
the Ras protein highlighting conserved functional regions as well as some
well known naturally occurring activating point mutations that inhibit GTP
hydrolysis and therefore lock the GTP-RAS complex in an active form. The
Switch regions are known to undergo large conformational changes upon
exchange of bound GDP for GTP (Souhami, 2002).
amino acid position. HVR, hypervariable region.
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candidate gene approach and a G to A transition in exon3 was identified.
This transition mutation results in an amino acid substitution at position 68
of the Ras1 protein, replacing a positively charged arginine within the
universally conserved Switch II region of Ras1 with a neutral glutamine
(Fig. 2B). The switch regions of Ras have been defined as regions that
undergo a large conformational change upon transition from the GTP- to the
GDP-bound state (Milburn et al., 1990). Detailed crystal structures have
revealed that residues in the Switch II region of Ras contact and are
stabilized by GAP, allowing them to participate in the catalysis of GTP
(Scheffzek et al., 1997). Mutations in the Switch II may therefore interfere
with Ras GTPase activity and possibly explains why several naturally
occurring oncogenic Ras mutations occur in this area (Fig. 2C) (Brose et al.,
2002; Lee et al., 2003). It therefore seemed feasible that the R68Q mutation
identified in Su(21-3s) flies could similarly result in a Ras protein with
enhanced signaling capacity.
We reasoned that if the Su(21-3s) phenotype is due to a gain of
function mutation in ras1, it should be revertible by introduction of a
second, intragenic loss of function mutation. To test this, we conducted a
reversion screen for loss of the Su(21-3s) suppression phenotype (Fig. 3A).
From a total of 80,000 F1 progeny that were screened, 15 phenotypic
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revertants were recovered. Based on lethality, 11 of these could be placed
into one of 4 complementation groups. One of these groups, containing the
revertants Su(21-3s)R11 and Su(21-3s)41, failed to complement the lethal null
ras85De1B allele and therefore corresponds to the ras85D (ras1) locus.
Analysis of these two revertants revealed intragenic loss-of-function
mutations in the ras1 coding sequence (Fig. 3F). One revertant contains a
31bp deletion in ras1 that results in a Ras1 protein truncated at amino acid
87. The second revertant contains an in frame 18bp deletion of ras1 that
eliminates amino acids 87-92 of the protein, which are known to be essential
for Ras function (Willumsen et al., 1986). These revertants greatly resemble
the null ras85De1B or ras85De2F alleles with regard to suppression of GMRhid and lethality (Fig. 3B-E and data not shown) and provide genetic
evidence for the hypothesis that Su(21-3s) is due to a revertible gain-offunction mutation in ras1.
Finally, as an allele of ras1, Su(21-3s) should interact genetically with
other members of the MAPK signaling pathway in a predictable manner.
We crossed GMR-hid10 flies in a Su(21-3s) background to mutants of MAPK
signaling and observed the extent of cell death in the eye (Fig. 4). MAPK
signaling mutants tested include argos, ras1, rolled and EGFR. In this
analysis, the Su(21-3s) mutant behaves as expected for a gain-of-function
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Fig. 3.3.

Screen to revert the Su(21-3s) suppressor phenotype.

A)

Homozygous Su(21-3s) males were treated with 4000 rad x-rays and crossed
to GMR-hid1M; Sb/TM6B females. 80,000 F1 progeny were screened for
loss of the Su(21-3s) suppression phenotype.

A total of 15 phenotypic

revertants were recovered, 11 of which could be placed into one of 4
complementation groups. One of these groups, containing revertants Su(213s)R11 and Su(21-3s)41, corresponds to the ras85D (ras1) locus. (B-E) The
suppression of the GMR-hid10 rough eye phenotype (B) by the Su(21-3s)
mutation (C) is lost in revertants Su(21-3s)R11 (D) and Su(21-3s)R41(E).
Genotypes: (B) GMR-hid10/+, (C) GMR-hid10/+;Su(21-3s)/+ (D) GMRhid10/+;Su(21-3s)R11/+ and (E) GMR-hid10/+;Su(21-3s)R41/+. F) A schematic
of the ras85D locus with exons boxed and coding regions stippled, depicting
the relative locations of the Su(21-3s) point mutation in exon 3 to the
deletions identified in Su(21-3s)R11 and Su(21-3s)R41 (labeled R11 and R41
respectively).

The red arrows correspond to PCR primers used in a

diagnostic for the Su(21-3s) point mutation. As illustrated by the sequence
alignments below, Su(21-3s)R41 contains a 31bp deletion compared to the
wildtype ras85D locus, resulting in a frameshift at amino acid 6 and a
truncation amino acid 87. The Su(21-3s)R11 mutant contains an 18bp in
frame deletion that removes amino acids 87-92. Sequences are labeled on
the left and numbers above correspond to basepair position in the ras1
cDNA. Also shown is a PCR diagnostic confirming that Su(21-3s)R11 (R11)
and Su(21-3s)41 (R41) retain the Su(21-3s) point mutation.
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ras1 allele. For example, Su(21-3s) is not much affected by loss-of-function
mutations in upstream components of MAPK signaling, such as argos or
EGFR (Fig. 4B,C), but is strongly ameliorated by loss of downstream
components, such as rolled (Fig. 4E).

Additionally, when a dominant

negative form of Ras1 (sev-ras1N17) is expressed in the eye, the suppressive
effects of Su(21-3s) are severely abrogated. Taken together, these data
confirm that Su(21-3s) is an allele of ras1 and we refer to Su(21-3s) from
here on as ras1R68Q.

Biochemical analysis of recombinant Ras1R68Q
To test the hypothesis that exchanging a positively charged arginine
with a neutral glutamine at position 68 of Ras1 results in a protein with a
deficient GTPase activity, the intrinsic GTPase rates of wildtype and mutant
Ras1 proteins were compared (Fig. 5).

Full length wildtype Ras1 and

mutant Ras1R68Q proteins were bacterially expressed and purified as Histagged fusion proteins, yielding large amounts of pure, catalytically active
enzyme. Intrinsic GTPase activity was measured with a kinetic phosphate
assay employing [γ-33P]GTP as substrate. This sensitive assay revealed that
Ras1R68Q has an intrinsic GTPase activity that is approximately 1/3 that of
wildtype Ras1, with enzymatic rates (kcat) of 0.020 min-1 and 0.063 min-1,
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Fig. 3.4.

The Su(21-3s)/ras1R68Q mutant differentially interacts with

components of the EGFR/MAPK pathway. Suppression of the GMR-hid10
induced eye ablation phenotype by Su(21-3s) (A vs A’) is not much affected
by loss of function mutations in upstream components of MAPK signaling
such as argos (B vs B’) or egfr (C vs C’), but is strongly ameliorated by loss
of downstream components, such as rolled (A’ vs E’). Additionally, when a
dominant negative form of Ras1 (sev-ras1N17) is expressed in the eye, the
suppressive effects of su(21-3s) are completely abrogated (A’ vs D’).
Genotypes are as indicated except that 21-3s refers to Su(21-3s)/ras1R68Q
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Fig. 3.5. Structural and biochemical analysis of wildtype and mutant Ras1.
(A-B) Three-dimensional crystal structure of human H-Ras (pink) bound to
the GTPase-activating domain of human GTPase-activating protein p120GAP
(GAP-334, blue) in the presence of aluminum fluoride (AlF3, green.) The
positions of oncogenic residues glycine-12 (G12) and glutamine-61 (Q61) as
well as the mutant residue in ras1R68Q flies, arginine-68 (R68), are shown in
yellow. The Switch II region of Ras, of which Q61 and R68 are a part, is
stabilized by GAP-334. (B) An enlargement of (A) showing the finger loop
of GAP-334, which supplies an arginine side chain (arginine-789) into the
active site of Ras to neutralize developing charges in the transition state
(Scheffzek et al., 1997). R68, located proximally to the catalytic site of Ras,
also extends a positively charged guanidinium group towards the active site.
The images were constructed using the Entrez software Cn3D with
mmdbId:51925 (Chen et al., 2003). Guanosine diphosphate (GDP,brown);
Mg2+ (grey).

(C) The intrinsic GTPase activities of affinity purified

drosophila Ras1wt (blue) and Ras1R68Q (black) were determined using a
kinetic phosphate assay employing [γ-33P]GTP as a substrate.

The

conditions of the assay are such that the reaction proceeds with unimolecular
kinetics and is insensitive to the amount of Ras protein employed (dashed vs.
undashed lines). The mutant Ras1R68Q has an intrinsic GTPase activity that
is approximately 1/3 that of wildtype Ras1 (kcat= 0.020 min-1 and 0.063 min-1
respectively.) (D) Human GAP-285 protein was purified by affinity
chromatography and its ability to stimulate wildtype and mutant Ras1
proteins was tested using a real-time fluorescent assay.

Ras1R68Q is

amenable to GAP stimulation, but to a lesser extent than is the wildtype
Ras1 protein. Data is the average of three independent experiments. Error
bars are in red. E) Typical intrinsic GTPase rates.
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E)

Ras

Intrinsic GTPase
Activity (min-1)

Wild type
G12V
G12D
G12R
G13V
Q61H
Q61L

0.028
0.002
0.001
0.0014
0.013
0.0019
0.0013

dmRaswt
0.063
dmRasR68Q 0.020
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respectively (Fig. 5C). This supports the prediction that the gain of function
nature of Ras1R68Q is due to a reduced GTPase activity. Additionally, since
many activating Ras mutations result in an enzyme that is insensitive to
GAPs, the ability of Ras1R68Q to be stimulated by GAP was also assessed.
Recombinant

human

GAP-285

protein

was

purified

by

affinity

chromatography and its ability to stimulate wildtype and mutant Ras1
proteins was tested using a sensitive real-time fluorescent assay. It was
determined that Ras1R68Q remains amenable to GAP stimulation, although to
a lesser extent than the wildtype Ras1 protein (Fig. 5D).

Unlike the

oncogenic, constitutively active mutant Ras1V12, whose GTPase activity is
completely refractory to stimulation by GAP, Ras1R68Q can be regulated by
GAP and is able to cycle between on and off states (Trahey and McCormick,
1987). This biochemical data supports the hypothesis that Ras1R68Q has a
reduced GTPase activity, remains in its active GTP-bound form for a
prolonged period of time and therefore has an enhanced signaling capacity,
but is still largely amenable to regulation, permitting nearly normal cellular
function and organismal development.
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Analysis of midline glia (MG) survival in ras1R68Q embryos
Drosophila midline glia (MG) cell survival during embryonic
development is exquisitely sensitive to MAPK activity levels (Bergmann et
al., 2002; Stemerdink and Jacobs, 1997).

During formation of the

Drosophila central nervous system, there are initially about ten MG cells per
segment at stage 13. Most of these undergo apoptosis in a rpr, hid and grim
dependent manner such that by stage 17, only three MG per segment survive
(Sonnenfeld and Jacobs, 1995; Zhou et al., 1997). We tested the effect of
ras1R68Q in this sensitive system. MG cells were visualized in wildtype and
ras1R68Q embryos using the MG-specific reporter fusion construct pslit-lacZ
and β-gal immunohistochemistry and clearly marked MG cells were
carefully counted. This analysis revealed an increase in the number of MG
cells in ras1R68Q embryos as compared to wildtype embryos (Fig. 6A,B).
Stage 17 wildtype embryos contained an average of 2.8 MG cells per
segment (n=448) whereas ras1R68Q embryos contained an average of 3.3 MG
cells per segment (n=420). This difference is statistically significant by an
unpaired t-test (p95≤0.0001) and is consistent with elevated MAPK survival
signaling in ras1R68Q flies (Fig. 6C).
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Fig. 3.6. Ras1R68Q mutant embryos contain extra midline glial (MG) cells.
MG were visualized in wildtype (A) and ras1R68Q (B) stage 17 embryos
using the MG-specific reporter construct P[slit-1.0-lacZ] and β-gal
immunohistochemistry. During development, the majority of MG undergo
apoptosis such that at this stage only about three MG per segment normally
survive. This analysis reveals an increase in the number of surviving MG
cells in ras1R68Q embryos as compared to wildtype embryos.

Arrows

indicate segments that clearly contain more than three MG cells.

(C)

Wildtype embryos contained an average of 2.8 MG cells per segment
(n=448) whereas ras1R68Q embryos contained an average of 3.3 MG cells per
segment (n=420). This difference is statistically significant by an unpaired
t-test (p95≤0.0001) and is consistent with enhanced MAPK signaling in
ras1R68Q mutants.
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Assay for supernumery R7 cells in ras1R68Q adult eyes
The adult Drosophila eye comprises about 800 ommatidia, each with a
precise, reproducible structure consisting of eight photoreceptors and 12
accessory cells (Cagan and Ready, 1989; Morante et al., 2007; Tomlinson,
1988).

Adoption of a neuronal cell fate by the precursor cell of R7

photoreceptors requires an inductive signal from the neighboring R8 cell and
is dependent on EGFR/MAPK signaling (Gaul et al., 1992; Simon et al.,
1991; Yang and Baker, 2001). In addition, cone cell precursors are capable
of acquiring an R7 cell fate if MAPK signaling is ectopically activated in
these cells, resulting in extra R7 cells that are easily visualized (Fortini et al.,
1992). To determine if the ras1R68Q mutation exerts effects in a paradigm
other than apoptosis, such as cell fate determination, semi-thin plastic
sections of adult eyes were prepared and analyzed for defects in ommatidia
formation. This analysis revealed two clear defects in ras1R68Q flies that are
typical for mutations that enhance RAS/MAPK signaling during eye
development.

First, we detected ommatidia with supernumery R7 cells

indicating that the ras1R68Q mutation can provide a sufficiently strong
inductive signal to drive cone cell precursors towards an R7 photoreceptor
fate (Fig. 7B). Second, we observed ommatidia missing an occasional outer
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Fig. 3.7.

Developmental analysis of the ras1R68Q mutant adult eye

phenotype. To determine if ras1R68Q exhibits phenotypes in a paradigm other
than apoptosis, semi-thin plastic sections of adult eyes were prepared and
analyzed for defects in ommatidia formation.

(A) Wildtype ommatidia

contain one R7 cell and six outer photoreceptor cells. (B-C) Ras1R68Q flies
contain two types of differentiation defects typical of mutations that increase
RAS/MAPK signaling during eye development, including supernumery R7
cells (arrowhead inside red outline, B) and missing outer photoreceptor cells
(arrow, C).

The developmental defects in retinal cell differentiation

observed here supports our hypothesis that flies carry a gain of function ras1
allele.

The schematic illustrates the major cell types present in the

ommatidia
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photoreceptor cell, also reported to be a phenotypic consequence of elevated
MAPK signaling (Fig. 7C) (Fortini et al., 1992).

The wings of ras1R68Q flies contain ectopic vein material
In addition to defects in the eye and midline glial cells, ras1R68Q flies
also show abnormalities in adult wing tissues. Homozygous ras1R68Q flies
contain an additional longitudinal “veinlet” seen to branch off the posterior
crossvein (Fig. 8). Additionly, an ectopic longitudinal vein appears directly
beneath the posterior crossvein and an ectopic crossvein appears between the
L4 and L5 wing veins near the hinge (Fig. 8B,F). These phenotypic defects
are remarkably similar to those observed in the wings of rlsem and DEREllipse
flies which exhibit elevated levels of MAPK signaling in the wing as they
are hypermorphic alleles (Brunner et al., 1994).

When UAS-ras1R68Q is

overexpressed in the wing using en-Gal4 an extensive amount of ectopic
wing vein material develops and blisters also commonly appear (Fig. 8D).
Overexpression of wildtype Ras1 in the same manner results in a significant
but less severe phenotype (Fig. 8C). We also attempted to express the
ras1V12 mutant in the wing using en-Gal4 but found this induced lethality, a
problematic feature of this ras1 allele.
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Fig. 3.8. Wing phenotypes associated with the ras1R68Q allele. Flies bearing
the ras1R68Q allele develop ectopic wing material including extra longitudinal
‘veinlets’ near the posterior crossvein (arrows, B) and an extra crossvein
near the wing hinge (red box, B and arrow, F). Overexpression of either
wildtype ras1 (C) or ras1R68Q (D) using the en-Gal4 driver results in the
deposition of substantial amounts of ectopic vein material.

(E,F)

Magnification of (A) and (B) encompassing the area boxed in red. The
arrow in (F) indicates an ectopic crossvein observed in ras1R68Q flies.
Genotypes are as indicated. ACV, anterior crossvein. L5, L5 wing vein.
Anterior is up.
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Overexpression in the eye of ras1R68Q, but not wildtype ras1, induces
severe overgrowth defects
To further establish that Ras1R68Q is an activated version of the Ras1
protein and to observe the phenotypic consequence, we ectopically
expressed ras1R68Q in the developing Drosophila eye. Overexpression of
wildtype Ras1 in various Drosophila tissues, even at the high levels obtained
by transgene expression, often results in mild or no observable phenotypic
effect (Fortini et al., 1992).

For this reason, studies of elevated Ras1

signaling in Drosophila largely rely on a constitutively active, nonregulatable ras1V12 mutant allele.

We similarly observed in eleven

independent transgenic lines that wildtype UAS-ras1 expression driven by
GMR-Gal4 was fully viable and had only minor effects on eye development
(Fig. 9B).

In sharp contrast, expression of UAS-ras1R68Q in seven

independent transgenic lines resulted in lethality for three and highly
distorted eyes that appear to exhibit both overgrowth and cell death
phenotypes for the remaining four (Fig. 9C-F).

Similar results were

obtained using sev-Gal4 to drive ras expression (Fig. 9G,H). Interestingly,
the anterior part of the eye appears to be much more sensitive to ras
expression by the sev-Gal4 driver since overgrowth is largely restricted to
this region.
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Fig. 3.9. Overexpression of ras in the eye induces developmental defects
causing both overgrowth and cell death phenotypes. Flies overexpressing
wildtype ras1 (B,G) exhibit relatively minor disruptions in eye patterning
and in the case of sev-Gal4 driven expression, a small but significant amount
of overgrowth occurs in the anterior part of the eye (G).

In contrast,

overexpression of ras1R68Q with GMR-Gal4 (C-F) causes severe overgrowth
and patterning disruptions.

An example from each of four independent

transgenic lines is shown to illustrate the range of phenotypes. Likewise,
overexpression of ras1R68Q with sev-Gal4 elicits a much more pronounced
overgrowth phenotype in the anterior part of the eye (H) compared to that of
wildtype ras1 (G). Genotypes: (A) GMR-Gal4/+, (B) GMR-Gal4/+;UASras1/+, (C-F) GMR-Gal4/+;UAS-ras1R68Q/+, (G) sev-Gal4/+;UAS-ras1/+,
(H) sev-Gal4/+;UAS-ras1R68Q/+.
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For purposes of comparison we attempted to express two different
UAS-ras1V12 alleles in the eye with both these drivers, but unsurprisingly,
again found this induced lethality (likely due to leaky expression and the fact
that ras1V12 can elicit non-cell autonomous death when overexpressed)
(Karim and Rubin, 1998).

These overexpression experiments further

support the notion that Ras1R68Q is an activated Ras protein that, in contrast
to the constitutively active Ras1V12 protein, remains amenable to negative
regulation and therefore is less biologically potent than Ras1V12. All else
being equal, this will permit overexpression of the ras1R68Q allele with a
broader array of transgenic promoters in a wider range of physiologic
contexts.

Discussion
The work presented here encompasses a genetic, molecular and
biochemical characterization of the first endogenous gain-of-function ras1
mutation to be identified in Drosophila.

This hypermorphic Ras allele,

Ras1R68Q, ranks among one of a very few viable Ras hypermorphs to be
identified in any multicellular organism. A curious fact considering the
hundreds and perhaps thousands of genetic screens carried out over the last
two decades or so with the express purpose of identifying components in the
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Ras/MAPK signaling pathway. In fact, only two viable gain-of-function
mutations in an essential Ras gene are well known, both of which are alleles
of the C. elegans Ras homolog let-60 (Sternberg and Han, 1998). One of
these alleles, let-60(G13E gf), has been independently isolated more than 5
times and when taken into account with the countless loss-of-function and
dominant negative Ras alleles that have been isolated across the animal
kingdom, it is clear that the Ras locus has been well saturated in mutagenesis
experiments. It appears that hypermorphs of Ras are very poorly tolerated in
biological systems and likely reflects the critical and ubiquitous role played
by Ras in biological systems.
Of course, many lethal gain-of-function Ras mutations have been
identified, particularly in the context of human tumorigenesis. An activating
mutation in one of the three human ras genes is found in ~20-30% of all
tumours, and in up to 90% of some types of carcinomas (Bos, 1989).
Invariably these oncogenic mutations occur at amino acid positions 12,13 or
61 and result in a very potent, constitutively active Ras protein. Normally,
Ras proteins cycle between a GTP-bound state in which they able to
productively engage downstream effectors and a GDP-bound state in which
they are inactive. The interconversion between these two states is tightly
regulated by two classes of enzymes: guanine nucleotide exchange factors
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(GEFs) which catalyze the exchange of GDP for GTP thereby activating
Ras, and GTPase activating enzymes (GAPs) which inactivate Ras by
dramatically stimulating the rate of GTP hydrolysis by Ras. Like Ras, these
regulatory proteins are highly conserved throughout many species (Colicelli,
2004).
In Drosophila, Ras1 has been implicated in

a number of

developmental processes, including the specification of ventral ectoderm
fate in the embryo, imaginal disc cell growth, differentiation of wing vein
and photoreceptor cells and regulation of embryonic midline glia survival by
suppression of apoptosis (Bergmann et al., 2002; Diaz-Benjumea and Hafen,
1994; Miller and Cagan, 1998; O'Keefe et al., 2007; Yang and Baker, 2001).
Genetic analysis in Drosophila has been pivotal in delineating the many
functions of Ras during development and pathogenesis and many of the
insights gleaned from these studies have proven applicable to other
organisms, including humans.
We have described the isolation and characterization of Ras1R68Q, a
viable gain-of-function Ras allele that contains a mutation in the universally
conserved Switch II region. Initially identified as a dominant suppressor of
hid induced cell death in the eye, we extended the characterization of its
suppression phenotype to larval hemocytes and in the setting of other MAPK
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pathway mutants. Moreover, we describe the phenotypic consequences of
this gain-of-function allele in several developmental contexts including its
effect on midline glia survival in embryos, R7 photoreceptor differentiation
in ommatidia and wing vein development.

Finally, we showed

biochemically that this Ras1 allele has a reduced intrinsic GTPase activity of
about one third that of wildtype Ras1, but that it remains responsive to GAP
stimulation. This latter fact is almost certainly why Ras1R68Q is viable.

Experimental Procedures
Fly stocks and genetics
The following fly stocks were used: GMR-rpr81 (White et al., 1996),
GMR-hid1M, GMR-hidAla3 and GMR-hidAla5 (Bergmann et al., 1998), GMRhid10 (Grether et al., 1995), GMR-grim (Chen et al., 1996), argIΔ7 (Freeman
et al., 1992), EGFR- = flbf2 (Nussleinvolhard et al., 1984), rl10a (Peverali et
al., 1996), sev-Ras1N17 (Karim et al., 1996), en-Gal4, sev-Gal4 (Therrien et
al., 1999), P[slit-1.0-lacZ] (Wharton and Crews, 1993), Hml-Gal4, 2xUASEGFP (J.A. Rodriguez, unpublished). Stocks for meiotic recombination
mapping (ru1 h1 th1 st1 cu1 sr1 es ca1 and ru1 h1 th1 st1 cu1 sr1 es Pr1
ca1/TM6B, Bri1, Tb1) and stocks for P-element induced male recombination
mapping (y1 w*; CyO, H{PDelta2-3}HoP2.1/Bc1 EgfrE1 as a source of
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transposase and all P-element insertion lines) were obtained from the
Bloomington Stock Center (Bloomington, IN). Flies carrying UAS-ras1 and
UAS-rasR68Q were generated by P element-mediated transformation
according to standard protocols. All other lines were generated by meiotic
recombination of the appropriate alleles.
Su(21-3s) was mapped by meiotic recombination using the rucuca
mapping chromosome. Mapping of the Su(21-3s) mutant was further refined
using P-element induced male recombination with the dominant markers Ly
and Pr (Chen et al., 1998). Reversion screens were performed as described
in Fig. 3. All crosses and suppression experiments were carried out at 25°C
except overexpression studies with en-Gal4, GMR-Gal4 and sev-Gal4 used
in conjunction with UAS-ras1R68Q or UAS-ras1, which were performed at
18°C.
To visualize larval hemocytes, wandering 3rd instar larva expressing
UAS-EGFP driven by Hml-Gal4 were collected and immobilized on ice
prior to imaging (Goto et al., 2003). MG cells in stage 17 embryos were
visualized using P[slit-1.0-lacZ] and β-gal immunohistochemistry as
previously described (Patel, 1994). The number of MG was averaged for
segments T2 to A5. Tangential sections (1 µm) of adult eyes were prepared
for analysis of ommatidia (Tomlinson and Ready, 1987).
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Biochemistry
A cDNA clone encoding Drosophila ras1 was obtained from the
Drosophila Genomics Resource Center (clone ID: RE53955) and the entire
ras1 ORF was subcloned into pBluescript (Stratagene). Mutant rasR68Q was
generated using the QuikChange II XL Site-Directed Mutagenesis Kit
(Stratagene). The Ras ORFs were then subcloned into pET-28a (Novagen)
in frame for an N-terminal His tag for expression and into pUAST (Brand
and Perrimon, 1993) for P element-mediated transformation.

Catalytic

human p120-Gap (GAP-285, amino acids 714-998, IMAGE Clone:
4829173, Open Biosystems) was subcloned into the pET41a vector
(Novagen)

to generate an N-terminal GST tag.

Fusion proteins were

expressed in BL21(DE3) E. coli (Invitrogen) and affinity purified on an
AKTA Purifier (Pharmacia) using a HisTrap FF column (GE Healthcare) for
Ras proteins and a GSTrap FF column (GE Healthcare) for GAP-285. Ras
purification was performed according to the procedure described for human
H-Ras (Boriack-Sjodin et al., 1998). GAP-285 was expressed by inducing
cells for 16 hours at 30°C with 0.2 mM IPTG.
Intrinsic GTPase activities were measured using [γ-33P]GTP (3000
Ci/mmol, NEN) and the EasyRad Phosphate Assay (Cytoskeleton) (Bollag
and McCormick, 1995). GAP-stimulated GTPase activities were measured
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with a real-time assay using the fluorescent substrate MDCC-PBP
(Invitrogen) and 2 µM Ras protein, with or without, 0.02 µM GAP-285
(Shutes and Der, 2005).
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